Continuously responsive epoxy amine cross linked silicon sol gel materials

合集下载

药物补给英语作文

药物补给英语作文

药物补给英语作文In the realm of healthcare, the continuity of medication is crucial for managing chronic conditions and ensuring patient well-being. A medication refill, simply put, is the process of obtaining more of a prescribed medicine after the initial supply has been used up. This essay will explore the significance of medication refill, the challenges that may arise, and the role of effective communication infacilitating this process.Firstly, the importance of timely medication refill cannot be overstated. For patients suffering from conditions such as hypertension, diabetes, or asthma, missing a dose can lead to a deterioration of their health condition. Regular refills help maintain a consistent level of medication in the body, which is essential for the treatment's efficacy.However, there are several challenges that can impede the refill process. One common issue is forgetfulness or lack of awareness about when a refill is due. This can be mitigated by setting reminders or using medication management apps that notify patients when it's time to refill their prescriptions.Another challenge is the financial burden that medication can impose on patients. The cost of prescriptions can be prohibitive, leading some to skip refills or split doses, which can be dangerous. To address this, healthcare providers and insurance companies often offer assistance programs orpayment plans to help patients afford their medications.The role of healthcare providers in the refill process is pivotal. Doctors and pharmacists must educate patients about the importance of adhering to their medication schedules. They should also be vigilant about potential side effects and drug interactions, adjusting prescriptions as necessary to ensure patient safety.Moreover, the advent of electronic health records and online pharmacies has streamlined the refill process. Patients can now request refills online or via mobile applications, making it more convenient and less time-consuming. This digital transformation has also improved the tracking of medication adherence, allowing healthcare providers to monitor patient compliance more effectively.In conclusion, medication refill is a critical component of healthcare management. It requires a combination of patient responsibility, provider education, and accessible healthcare systems to ensure that patients receive the medications they need in a timely manner. As the healthcare landscape continues to evolve, it is imperative that these systems adapt to meet the needs of patients, ultimately improving health outcomes and quality of life.。

2014年欧洲加速康复外科协会《胃切除术加速康复外科指南》热点问题解读

2014年欧洲加速康复外科协会《胃切除术加速康复外科指南》热点问题解读
关帕。9 o。而本《指南》则认为:施行胃切除术患者,
3.4伤口导管镇痛和腹横肌平面阻滞
胃切除术后的患者应使用伤口导管和腹横肌 平面阻滞,由此避免侵入性操作可能带来的低血压 损害,减少硬膜外血肿及感染的发生率。同时伤口 导管镇痛和腹横肌平面阻滞可显著减少术后疼痛、 恶心、呕吐的发生,减少术后阿片类药物的使用
期胃癌手术患者∞-。
康复外科协会根据最新循证医学证据组织专家制订了《胃
切除术加速康复外科指南》。现就该指南中热点问题做一简 要解读,以期为我国该领域的临床工作提供循证医学证据。
【关键词】加速康复外科;指南;治疗;解读
Understanding of the 2014 guidelines
I"or
enhanced recovery
量[20‘21|。腹膜外伤口导管镇痛和腹横肌平面阻滞 在结直肠手术中也能起到相似的效果心1|。但其局
术前不应常规使用人工营养支持;但存在明显营养
不良的患者,推荐术前口服补充营养或行肠内营养
支持治疗¨…。
证据质量:极低
限性在于显著镇痛效果仅能维持至术后48 h,且与 导管放置的位置(皮下、筋膜下、腹膜外)以及局部 麻醉药物的类型、浓度和剂量有关怛1I。 证据质量:伤口导管——低到中等,腹横肌平面 阻滞——低
after
gastrectomy published by European Enhanced Recovery Zhang Shu,Jiang Zhiwei,Li Jieshou.
After Surgery Society Research Institute Hospital
of
General Surgery
line;Therapy;
质量级别分为:高、中、低和极低;推荐强度分为:强 和弱。证据级别受试验设计和样本量偏倚影响,如 果有不一致的结果或缺少直接证据,则由相近领域 手术进行推断。《指南》提供的建议不仅仅基于证 据的质量,还取决于对临床工作的指导意义和价值, 如低质量的证据可能值得强烈推荐,反之亦然。

防撞系统英文

防撞系统英文

The introduce of the automobile anti-collision control systemThe accident of automobile rear-end collision has taken place frequently in recent years,and rear-end collision warning system has good use in improving expressway traffic safety,so the warning system has been paid more attention in the world. The vehicle collision avoidance alarm apparatus system was introdued according to the ultrasonic measurement distance’s system . Th e system can automaticanlly xeamine the distance between the back and the nearest obstacle ( or the distance among cars ) whicwould be demonstarted through LED that when it arrives the limit distance ,the system can send out the warning and reminds the driver for preventing the vehicle colliding . The experimental results showed that,the system illustrates a good prospect of application and xetension highways, streets, parking, garage and other crowded places narrow reverse, the driver should not only forward but also looking back, a little rear-end careless accidents can occur. According to related statistics, 15% of motor vehicle collisions when the vehicle is reversing, as the capacity of the latter caused by bad.So after the increase of motor vehicles as the ability to detect obstacles on the development of the rear of the car reversing radar has become the research hotspot in recent years. Security to avoid obstacles on the premise that the rapid and accurate measurement of obstructions and the distance between motor vehicles. To this end, the design of a single-chip microcomputer as the core, the use of ultrasonic ranging to achieve non-contact reversing radar system. Generally refers to ultrasonic frequencies above 20 kHz mechanical waves, with penetrating, and attenuation of small, reflecting the ability and so on. Work, the ultrasonic transmitter continuously emits a series of consecutive pulses to the measurement of logic circuits to provide a short pulse. Finally, signal processing devices based on the received signal for processing the time difference, automatic calculation of turnout and the distance between obstacles. Ultrasonic Ranging simple, low cost, easy production, but the transmission speed by a larger weather can not be precise range; In addition, the ultrasonic energy and the attenuation is directly proportional to the square of the distance, the farther the distance, the lower sensitivity and thus Ultrasonic Ranging way so that only apply to a shorter distance. At present, ultrasonic range finder at home and abroad in general, the ideal distance of the measurement 4 ~ 5 m, thusreversing radar are used in cars, such as close range in this paper, according to the spread of sound waves in air reflection to ultrasonic transducer interface components, based on MCU AT89C51 ultrasonic range-finder. Designed by the ultrasonic transmitter module, receiver module, single-chip processing module, a digital display and alarm sound and light display module,such as parts, the text in detail the range of hardware devices, detection theory, methods and software architecture.In one aspect the present invention broadly resides in a self-propelled robotic vehicle responsive to a radio frequency signal from a transmitter means including a vehicle frame means; at least two spaced apart receiver means adapted to receive the signal from the transmitter means; a processor operatively associated with the receiver means, said processor is programmed to process input from the at least two spaced apart receiver means to locate the position of the transmitter means and produce an electrical signal for the vehicle to move relative to the transmitter means in accordance with the processor programming; and drive means supported on the vehicle frame means and adapted to receive and act on the electrical signal sent from the processor to move the vehicle in accordance with the processor programming.In a further aspect the present invention broadly resides in a system for a self- propelled robotic vehicle including transmitter means able to transmit a radio frequency signal; a self-propelled vehicle including a vehicle frame means; at least two spaced apart receiver means adapted to receive the signal from the transmitter means; a processor operatively associated with the receiver means, said processor is programmed to process input from the at least two spaced apart receivers to locate the position of the transmitter means and produce an electrical signal for the vehicle to move relative to the transmitter means in accordance with the processor programming; and drive means supported on the vehicle frame means and adapted to receive and act on the electrical signal sent from the processor to move the vehicle in accordance with the processor programming.The receiver means preferably includes two spaced apart antennas with each operatively linked to a receiver. The receivers are preferably Super Heterodyne typeor Near Zero IF type. The antennas are preferably spaced apart at a distance from each other. More preferably, the antennas are 25cm or more spaced apart from each other.The two spaced apart antennas are preferably operatively connected to enable the processor to process the signal inputs to determine the location of the transmitter. The receiving antennas are preferably arranged with one antenna peak tuned and the other is dip tuned so that they are 90 degrees out of phase. The processor preferably can combine the two signals for a summed RSSI reading and measure a phase shift to determine the position of the transmitter means.Preferably the antennas have resonator coils that enable them to be dynamically tuned. With tuning the antenna, the predefined frequency is preferably set by varying the capacitance of the coil by the voltage to peak tune the antenna to the definedfrequency.The transmitter means is preferably a transponder that transmits a signal but not receive a signal. The transmitter means is preferably portable. Alternately transmitter means may be a transponder which is activated on receiving a radio frequency signal from the vehicle and transmits a location signal back to the vehicle. Preferably the transponder is wearable and has a frequency between 200Khz to 8 Ghertz. More preferably the transponder has a frequency between 300 Khz and 500 Khz.The transponder preferably has a plurality of capacitors so that the transponder antenna can be dynamically tuned and shifted in 5 KHz increments to form 5 KHz channels. The signal is carrier modulated by frequency shift keying (FSK) where the keying rate is 300 Htz and the frequency shift is +/- 1 Khz either side of the carrier forming a 300Htz tone.The radio frequency signal is preferably a suitable frequency to enable identification of the vehicle and activation of the vehicle to move in accordance with the processor programming. The radio frequency signals are preferably arranged in channels. The signal processing is preferably able to identify separate transmitter channels and negate any adjacent channel interference.Within the defined range of the radio frequency signals, the number of vehicles responding to transponder specific signals within an area may be increased by one or more methods including random transmission cycle for the transponders where the transmissions are coded so that they can be decoded and used by the corresponding vehicle. Alternately the frequency from the transponder may be modulated at a FSK keying rate of 500Htz with +/- 1 Khz frequency shift so that the receivers can identify their corresponding transponder. Furthermore the transponder preferably has a random number generator which is used to trigger transmit time so that transmissions are not synchronized to avoid the situation where multiple simultaneous transmissions are received by a receiver.。

每周只需注射一次,3个月即可轻松减掉10斤肥肉能让你管住嘴的减肥神药真的来了 临床大发现

每周只需注射一次,3个月即可轻松减掉10斤肥肉能让你管住嘴的减肥神药真的来了  临床大发现

每周只需注射一次,3个月即可轻松减掉10斤肥肉。

能让你管住嘴的减肥神药真的来了临床大发现“管住嘴,迈开腿”简简单单六个字,就道出了减肥的真谛。

然而,面对那么多的美食诱惑,光这前三个字就足以让无数人的减肥大业半途而废了。

不过,好消息来了!最近,肥胖研究领域中的著名期刊《糖尿病,肥胖和代谢》杂志刊登的一项临床研究[1]显示,诺和诺德公司开发的索马鲁肽,可以抑制食欲,让你轻松“管住嘴”。

只需一周注射1次,连续注射12周后,就可减重10斤!而且,在这减轻的体重中,主要还是体内的脂肪组织,药物对除脂肪以外的去脂体重影响很小。

不光有效,还很安全!这项研究的通讯作者,来自英国利兹大学的John Blundell 教授表示,“索马鲁肽的作用是非常令人惊讶的,我们在12周内就观察到了其他减肥药物需要6个月才能达到的效果。

它减少了饥饿感和食欲,让患者能更好地控制饮食摄入。

”[2] John Blundell教授索马鲁肽(Semaglutide)本身是一款针对2型糖尿病的降糖药,主要成分为胰高血糖素样肽-1(GLP-1)类似物。

GLP-1是一种由小肠分泌的激素,在血液中葡萄糖水平升高时促进胰岛素的合成和分泌。

GLP-1进入人体后很容易被酶降解,天然的GLP-1半衰期仅有几分钟,所以,为了让它更长久的工作,研究人员会对它进行一些结构上的改造,在保留功能的同时不那么容易被酶降解。

这样得到的GLP-1类似物药物,比如大名鼎鼎的利拉鲁肽,可以将注射频率减缓到每天1~2次。

而索马鲁肽可以说是它们的“升级版”,在经过改造后,它的半衰期可延长至大约1周,因此注射一次的效果可以维持大约一周的时间[3],对于患者来说更方便。

在不久前公布的全球大型III期临床试验中,索马鲁肽表现优秀,既能控制血糖,还可以保护心血管,这为它在上周赢得了FDA内分泌及代谢药物专家咨询委员会16:0的支持率,不出意外的话,索马鲁肽上市在即[4]。

不少分析人士预测它未来十年内的销售峰值将超百亿,成为治疗2型糖尿病中最好的降糖药。

医药行业专业英语词汇

医药行业专业英语词汇

医药行业专业英语词汇(非常有用)FDA和EDQM术语: CLINICAL?TRIAL:临床试验? ANIMAL?TRIAL:动物试验? ACCELERATED?APPROVAL:加速批准? STANDARD?DRUG:标准药物? INVESTIGATOR:研究人员;调研人员PREPARING?AND?SUBMITTING:起草和申报? SUBMISSION:申报;递交? BENIFIT(S):受益? RISK (S):受害? DRUG?PRODUCT:药物产品? DRUG?SUBSTANCE:原料药? ESTABLISHED?NAME:确定的名称? GENERIC?NAME:非专利名称? PROPRIETARY?NAME:专有名称;? INN (INTERNATIONAL?NONPROPRIETARY?NAME):国际非专有名称? ADVERSE?EFFECT:副作用? ADVERSE?REACTION:不良反应? PROTOCOL:方案? ARCHIVAL?COPY:存档用副本? REVIEW?COPY:审查用副本? OFFICIAL?COMPENDIUM:法定药典(主要指USP、?NF).? USP(THE?UNITED?STATES?PHARMACOPEIA):美国药典 NF(NATIONAL?FORMULARY):(美国)国家处方集? OFFICIAL=PHARMACOPEIAL=?COMPENDIAL:药典的;法定的;官方的? AGENCY:审理部门(指FDA)? IDENTITY:真伪;鉴别;特性? STRENGTH:规格;规格含量(每一剂量单位所含有效成分的量)? LABELED?AMOUNT:标示量? REGULATORY?SPECIFICATION:质量管理规格标准(NDA提供)? REGULATORY?METHODOLOGY:质量管理方法? REGULATORY?METHODS?VALIDATION:管理用分析方法的验证 COS/CEP?欧洲药典符合性认证 ICH(International?Conference?on?Harmonization?of?Technical?Requirements?for?Registrat ion?of?Pharmaceuticals?for?Human?Use)人用药物注册技术要求国际协调会议 ICH文件分为质量、安全性、有效性和综合学科4类。

最新CRRT指南规范.doc

最新CRRT指南规范.doc

2010年中华重症学会CRRT指南血液净化(blood purification)技术指各种连续或间断清除体内过多水分、溶质方法的总称,该技术是在肾脏替代治疗技术的基础上逐步发展而来。

血液净化方法有肾脏替代治疗、血液灌流、免疫吸附、内毒素吸附和血浆置换等。

每一种血液净化方式都各有特点,且各适用于不同疾病或不同疾病状态。

本指南仅对ICU中应用最多的肾脏替代治疗(renal replacement therapy, RRT)进行讨论并提出建议。

血液净化概念和常见种类上世纪70年代末,RRT主要用于治疗重症急性肾功能衰竭患者。

随着技术不断发展,近30年,RRT已用于全身过度炎症反应(如严重创伤、重症急性胰腺炎等)、脓毒血症、中毒和多脏器功能衰竭等危重症的救治。

另外,对重症患者并发的特殊情况,如严重电解质紊乱、过高热等,RRT也能显示良好疗效。

RRT在重症患者救治中起着极其重要的作用,是ICU医师应予掌握的基本技术。

基于此,国内ICU有关专家根据循证医学证据制定本指南。

制定本指南的意义循证医学证据按照Delphi 分级标准(见表1)。

循证医学证据时间跨度为1999年1月至2009年3月;数据主要来自Medline、Evidence-Based Medicine Reviews (EBMR)、Lippincott Williams & Wilkins (LWW)和万方数据库等4个数据库。

主题词采用以下几个:①hemofiltration;②dialysis;③renal replacement therapy;④continuous renal replacement therapy;⑤critical illness;⑥acute renal failureDelphi 循证医学分级标准指导建议分级A 至少有2项Ⅰ级研究结果支持B 仅有1项Ⅰ级结果支持C 仅有Ⅱ级研究结果支持D 至少有1项Ⅲ级研究结果支持E 仅有Ⅳ级或Ⅴ级研究结果支持研究文献分级Ⅰ大样本、随机研究,结论确定,假阳性或假阴性错误的风险较低Ⅱ小样本、随机研究,结论不确定,假阳性和/或假阴性错误的风险较高Ⅲ非随机,同期对照研究Ⅳ非随机,历史对照研究和专家意见Ⅴ系列病例报道,非对照研究和专家意见第一部分血液净化的相关概念一.相关概念血液净化包括RRT、血液灌流(hemoperfusion,HP)及血浆置换(plasma exchange,PE)等,其中RRT是本指南重点。

化学工程与工艺 专业英语词表(华东理工)0204192325

化学工程与工艺 专业英语词表(华东理工)0204192325

专业英语词表(2002.11.修订)(加注* 者为专业英语学位考试中词汇英译汉和汉译英的考试范围。

)* abrasion n. 磨损,磨蚀,剥蚀* absorption n.吸收(作用)abundance n. 丰度;丰富;(大,分布,数)量* accessory n. (pl.) 辅助设备[装置],附件 a. 附属的,辅助的accidenetal error 偶然[随机]误差* accuracy n. 准确性[度]* acetate n. 醋酸盐[酯],乙酸盐[酯,根];醋酸纤维素* acetic acid 醋酸acetyl n. 乙酰基* acetylene n. 乙炔actinium n. 锕Acactivated carbon 活性炭* activity n. 活度;活动性* additive n. 添加剂,加成剂 a. 附加的,加成的adhesive n. 胶粘剂,粘结剂* adiabatic a. 绝热的admix v. 掺[混]合* adsorbent n. 吸附剂,吸附物质adsorber n. 吸附器* adsorption n.吸附(作用)* aerate vt. 充气,鼓气,通风,鼓风aer(o)- 空气;气体aerobic a. 好氧的,需氧的,有氧的* affinity n. 亲和力,亲和势,化合力agglomeration n. 附聚,凝聚,* agitator n. 搅拌器,搅拌装置airtightness n. 气密性,密封性-al 醛* alcohol n.(乙)醇,酒精-aldehyde 醛algebraic a. 代数(学)的algorithm n. 算术,算法* aliphatic a. 脂肪族的,无环的alkali n. 碱(性,质),强碱* alkaline n. 碱性 a.强碱的* alkane n. 烷(属)烃,(链)烷* alkene n. 烃烯* alkyl n. 烷基,烃基* alkylation n. 烷基化,烷基取代* alkyne n. 炔(属)烃* aluminum n. =aluminium铝Al amalgamation n. 合并,混合;汞合,汞齐作用-amide 酰胺-amine 胺amine n. 胺amino- 氨基* ammonia n. 氨(水)* ammonium n. 铵(基)* amorphous a. 无定形的, 非晶体的* analogy n. 类似,相似(性),类推anatomy n.解剖,分解;构造,组织-ane 烷angular a. 角的,角度的,有角的* anhydrous a. 无水的* anionic a. 阴[负]离子的anisotropic a. 各相异性的,非均质的* anode n. 阳极,正极antibiotic n. 抗生[菌]素,抗生素学a. 抗菌的antiknock a. 抗爆的,防爆的,抗震的antimony n. 锑Sb* antioxidant n. 抗氧化剂,防老化剂* aqueous a. (含,多,似)水的,水成[化,样,多]的argon n. 氩Ar* aromatic a. 芳香(族)的,芳(香)烃的aromatization n. 芳构化* array n. 序,列,组;族,系,类artificial intelligence人工智能* aryl n. 芳基asphalt n. 沥青,柏油-ate 用于由词尾为-ic的酸所成的盐类或酯类的名称atomize vt. 使雾化,喷雾attainment n. 开工率attrition n. 磨损,研磨naught n. 无(价值),零authenticity n. 可靠性,真实性autoclave n. 压煮器, 高压釜* azeotrope n. 恒沸物,共沸混合物backbone n. 构架, 骨干, 主要成分* back-mixing 返混bacteria n. (bacterium的复数)细菌* baffle n. 挡板;折流板;缓冲板bank n. 一排,排,列,群barium n. 钡Ba* base n. 碱* batch a.间歇的,分批的bench n. 实验台,装置* benzene n. 苯bi- 二,两个,双bifunctional a. 双官能团的binary a.;n. 二,二元的biochemical a. 生物化学的biodegradable a. 可生物降解的bismuth n. 铋Bibitumen n. 沥青bleaching n. 漂白 a. 漂白的boiler n. 锅炉boiling point 沸点bombardment n. 照射,辐照;轰击,打击* bond n.;v.(化学)键,键合borate n. 硼酸盐[酯]boric acid 硼酸boron n. 硼Bbottom n. (pl.) 底部沉积物,残留物,残渣* boundary layer边界层brine n.盐水,卤水,海水bromide n. 硼化物* bromine n. 溴Btu = British thermal unit 英热量单位(=252卡)bubble column 鼓泡塔bubble-cap tower 泡罩塔budget n. 预算* buffer n.; vt. 缓冲,缓冲剂* bulk density 堆积密度bulk polymerization本体聚合bulk a. 散装的;大块的* bump v. 扰动,暴沸;冲击,造成凹凸* buoyancy n. 浮力,浮性buoyant a. 有浮力的,能浮的,易浮的butadiene n. 丁二烯butane n. 丁烷butene n. 丁烯* butyl n. 丁基cadmium n. 镉Cdcalandria n. 排管式,加热管群calcine v.; n. 煅烧,烧成(灰)* calcium n. 钙Ca* calorific value 热值,发热量* capillary n.; a. 毛细作用(的),毛细管(的)capital-intensive a. 资本密集的,资本集约的capsule n. 胶囊;(密封)(座)舱carbide n. 碳化物;碳化钙* carbohydrate n. 碳水化合物,糖carbon black 炭黑* carbon n. 碳C* carbonate n. 碳酸盐,碳酸脂vt. 碳化,使化合成碳酸盐(酯);充碳酸气于carbonization n. 焦化,碳化处理,渗碳* carbonyl n. 羧基carbonylation n. 羧化作用* carboxyl n. 羰基* carrier n. 载体* cascade v.;n. 级联,串级;梯流,阶流式布置catalysis n. 催化(作用,反应)* catalyst n. 催化剂catalytic a. 催化的category n. 种类,类型,范畴* cathode n. 阴极,负极cationic a. 阳[正]离子的* caustic a. 苛性的n. 苛性物,氢氧化物cellular a. 多孔的,细胞的,由细胞组成的cellulose n. 纤维素,细胞膜质 a. 细胞的central downtake 中央降液管centrifugal a. 离心力的,利用离心力的* centrifuge n.;v. 离心;离心机,离心器ceramic a. 陶器的,陶瓷的,制陶的certitude n. 确实,必然性acetone n. 丙酮CFC = chlorofluorocarbon n. 含氯氟烃char n. 炭,木炭* chelation n. 螯合作用chemical vapor deposition化学气相淀积chlor(o)- 氯(化)* chloralkali n.氯碱chlorate n. 氯酸盐* chloride n. 氯化物,漂白剂* chlorine n.氯(气)Clchlorofluorocarbon n. 含氯氟烃(CFC)chromate n. 铬酸盐* chromatography n. 色谱(法,学),色层法* chromium n. 铬Crcis- 顺式clone n. 克隆,无性繁殖系* coagulation n. 凝结[聚, 固];胶凝, 絮凝coal carbonization 煤干馏coal-tar 煤焦油coarse a. 粗的,大的* cobalt n. 钴Cococatalyst n. 助(辅)催化剂* cocurrent n. 并流* coefficient n. 系数coke n. 焦炭,焦vt. 炼焦,焦化colloid n. 胶体,胶粒 a. 胶状的,胶体的* combustion n. 燃烧commence v. 开始,开始(做),开工comminute vt. 粉碎,磨碎,分割commission v. 交工试运转,投产commodity n. 日用品,商品compactness n. 致密(性),密集(性),紧凑compatibility n. 兼容性,相容性,适应性complement n. 补充,互补,补充物;配套* composite n. 复合材料, 合成[复合, 组合]物* composition n. 组成,成分,结构concrete n. 混凝土 a. 混凝土的condensate n. 冷凝物,冷凝液v. 冷凝,凝结* condenser n. 冷凝器* conduction n. 传导(性,率,系数),导热[电](性,率,系数)* conductivity n. 传导率,导热系数conduit n. 导管,输送管,(大)管道* configuration n. 构造,结构;外形,轮廓confluence n. 合流(点),汇合(处);集合,聚集conical a. (圆)锥形的* conserve vt.守恒;节省;保存* consistence n. 一致性;稠度* constituent n. 组成,组分,成分constraint n. 限制,制约,约束constriction n. 收缩[敛];缩紧* contaminate vt. 污染,弄脏,毒害* continuum n. 连续介质;连续(统一体);连续光谱* convection n. (热,电)对流,迁移converge v. 会聚,汇合,[数]收敛* coordinate n. 坐标;配位 a. 坐标的,配位的v. 配合,配位coordination n. 配位, 配合copolymer n.共聚物* correlation n. 相关(性),(相互,对比)关系* corrosion n. 腐蚀,锈蚀* counter current 逆流counterpart n. 对应物,配对物,对方;一对东西中之一,副本covalent a. 共价的* cracking n. 裂化,裂解* criterion n. (pl.) criteria判据,准则,判断标准* critical velocity 临界速度* cross section (横)截面,剖面,断面* cross-current n. 错流,正交流cross-flow 错流,交叉流动,横向流动cross-link v. (聚合物)交联,横向耦合* cryogenic a. 冷冻的,深冷的,低温的* crystal n. 结晶,晶体,晶粒;水晶石英crystalline a. 结晶的,结晶状的;水晶的* crystallization n. 结晶(作用,过程)CSTR =continuously stirred tankreactor 连续搅拌釜反应器culture n.;vt. (人工,细菌)培养[繁殖],栽培;文化[明]cure v. 塑化,固化,硫化,硬化;处理curriculum n.(一门,全部)课程* cycloalkane n. 环烷烃cyclohexane n. 环已烷* cyclone n. 旋风分离器,旋流器deactivate vt. 减活,去活化,钝化debit vt.;n. (记入)借方deca- 十,癸decane n. 癸烷decantation n. 倾析(法),倾滤,滗析* decline v.;n. 下降,减少,倾斜,衰落* decomposition n. 分解, 离解* degradation n. 降解,退化,衰变,降级degree of freedom 自由度degree of polymerization聚合度* dehydrate v.; n. 脱水,干燥dehydrogenation n. 脱氢(作用)*dense-phase 密相*density n. 密度;稠密(性,度)deoxyribonucleic acid脱氧核糖核酸deplete vt. 放空,耗尽,使枯竭;贫化,减少* derivative n. 衍生物;导数desalt vt. 脱盐* desulphurisation n. 脱硫,除硫detergent n.洗涤剂,去污剂deterioation n. 退化,变质,降低(品质)di- 二,重,双* diagnose v. 判断,诊断;确定,分析,识别,断定(···的原因)* dialysis n. 渗析,渗透diamond n. 金刚石,钻石* diaphragm n. 隔膜,隔板diesel oil 柴油diesel n. 内燃机,柴油机* differential a.; n. 微分(的),差分(的);(有)差别(的)differentiate v. 区分,区别;求微分,求导数* diffuse v. 扩散,散布* dilute a. 稀(薄,释)的,淡的v.稀释,冲淡*dilute-phase 稀相dimensionless a. 无因次的,无量纲的* dimentional a. ···维的;因次的;维数的;尺寸的* diminish v. 减少,递减,削弱,由大变小dipole n. 偶极(子)* discrete a. 离散的,不连续的,独立的,个别的dispatch vt.(迅速地)发送,派遣;迅速办理,了结* dispersion n. 分散(体系,作用);扩散(现象)dissipate v. 使耗散,消除,消耗dissolution n. 溶解,溶化* dissolve v.;n. 使溶解,溶化* distil(l) vt. 蒸馏,用蒸馏法提取;提取···的精华distillate n. 馏出物,馏出液;精华* distillation n. 蒸馏(作用),馏份* down time 停车时间,故障期downcomer n. 降液管* drag n. 阻力,曳力* droplet n. 液滴,微滴,小滴duct n. (导,输送)管,(管,渠,地,风,烟)道,槽* dumped packing 乱堆填料dyestuff n. 染料,颜料,着色剂dynamic a. 动力(学)的,动态的* dynamics n. (动)力学,动态(特性)earth vt. 接地,通地ebullating bed 沸腾床* ecosystem n. 生态系(统)* eddy n. 漩涡,涡流* effluent a.; n 流出(的,物),废水及废气elastomer n. 合成橡胶,人造橡胶;弹性体,高弹体electrochemical a. 电化学的* electrode n. 电极* electrodialysis n. 电渗析electrolyse vt. 电解(= electrolyze)* electrolysis n. 电解(法,作用),电分析electrostatic a. 静电的* eluent n. 洗脱液,洗脱剂* elution n. 洗提,洗出* emission-free a. 无排放的,零排放的emulsion polymerization乳液聚合* emulsion n. 乳胶,乳(化,状,(浊)液,乳剂encompass vt.包含,包括;完成;围绕encyclopedia n. 百科全书;某科全书* endothermic a. 吸热的end-product n. 最后产物,最终结果-ene 烯enhance vt.提高,增强* enrich v.使浓缩,增浓* enthalpy n. 焓,热函,(单位质量的)热含量* entrainment n. 挟带;雾沫夹带* entropy n. 熵envisage vt. 设想,预计,重视* enzyme n. 酶,酵素epoxy n. 环氧树脂equality n. 等式,相等* equilibrium stage 平衡级* equilibrium n. 平衡erosion n. 磨蚀,风化,腐蚀,侵蚀* ester n. 酯ethane n. 乙烷* ethanol n. 乙醇,酒精ethene n. 乙烯* ether n. 醚,乙醚;以太ethics n. 职业规矩,道德标准,伦理观* ethyl n. 乙基,乙烷基* ethylene n. 乙烯* evaporation n. 蒸发,挥发,汽化* exergy n. 有用能,火用* exothermic a. 放热的expenditure n.(时间、金钱等的)支出,花费,使用expert system 专家系统* explosive limit 爆炸极限exponent n. 指数,幂(数),阶externalize vt. 使客观化,使具体化,给···以外形* extract n. 萃取相,萃取液vt. 萃取,提炼* extraction n. 萃取,提炼;抽出物,提取物* fabricate vt. 制造,生产,制备;装配,安装,组合falling film evaporator降膜式蒸发器* feed n. 进料,加料;加工原料fermentation n. 发酵ferri- 铁ferro- 亚铁ferrous a. (亚,二价,含)铁的,铁类的ferrum n. 铁* fertilizer n. 肥料(尤指化学肥料)fiberglass n. 玻璃纤维filament n. (细)丝,(细)线;灯丝,游丝filled tower 填料塔filler n. 填料,填充物filter aid 助滤剂* filter n. (过)滤器[机,层,纸]v. 过滤filtrate v. 过滤,滤除n. 滤液* filtration n. 过滤* fine chemical 精细化学药品finishing n. 精加工,最终加工* finite a. 有限的,受限制的* fission n. 裂变* fixed bed 固定床* flammability n. 易燃性,可燃性,燃烧性flange n. 法兰flask n. 烧瓶,长颈瓶* flooding n. 液泛,溢流* flow sheet 工艺流程图,程序方框图* fluctuation n. 脉动,波动,起伏,增减flue n. 烟道,风道fluidization n. 流态化* fluidized bed 流化床fluo- 氟,荧光fluorescence n. 荧光* fluoride n. 氟化物* fluorine n. 氟Ffluoro- 氟代* flux n. 通量foam v. (使)起泡沫,变泡沫n. 泡沫forced circulation强制循环-form 仿formaldehyde n. 甲醛* formulate vt. 配方[制],按配方制造formulation n.配方,组成;公式化,列方程式* fossil fuel 化石燃料,石油* foul n. 污物[垢] v. 结垢,弄脏* fraction n. 馏份,分馏物;分数,部分fractional distillation 分馏(作用)fractionate vt. 使分馏,把···分成几部分free radical mechanism自由基机理free radical 自由基,游离基* freeze drying 冷冻干燥* friction n. 摩擦,摩擦力froth flotation 泡沫浮选* fugacity n. 逸度* functional group 官能团funnel n. 漏斗 a. 漏斗状的* fuse v. 熔融,熔化gallon n.加仑gas oil 粗柴油, 瓦斯油, 汽油* gasification n. 气化(法,作用)gasifier n. 气化炉gauge n. 表,计,规* gel n. 凝胶(体),冻胶gene n. 基因* generalization n. 归纳,概述,通则;普遍化,法则化genetics n. 遗传学glucose n. 葡萄糖;右旋糖glycerol n. 甘油,丙三醇gold n. 金Au* gradient n. 梯度,变化率,坡度granulate vt. 使成颗粒,使成粒状graphite n. 石墨gravitational fild 重力场*gravity settling 重力沉降greenhouse n. 温室,暖房* halogen n. 卤素hardware n. 硬件,硬设备,计算机H-bond n. 氢键* heat exchanger 热交换器helium n. 氦hepta- 七,庚heptane n. 庚烷* heptyl n. 庚基heteroatom n. 杂原子, 异质原子heterocyclic a. 杂环的* heterogeneous a. 多相的, 非均匀的HETP = height equivalent to a theoreticalplate等板高度,理论塔板的当量高度HETS = height equivalent to a theoreticalstage等板高度,理论塔板的当量高度hexa- 六,己hexane n. 己烷* hexyl n. 己基hierarchy n. 体系,系统;层次* holdup n. 滞留量,滞液量* homogeneous a. 均相的,均匀的,同质的HTU = height of a transferunit传质单元高度* humidification n. 增湿作用,湿润* humidity n. 湿度,湿气,水分含量humidifier n. 增湿器,湿润器* hydrate n. 水合物v. (使)水合,(使)成水合物hydration n. 水合作用hydride n. 氢化物hydraulics n. 水力学;液压系统* hydrocarbon n. 烃,碳氢化合物* hydrochloric acid 盐酸* hydrocracking n. 加氢裂化, 氢化裂解hydrodesulfurization n. 加氢脱硫过程* hydrodynamics n. 流体动力学hydrofluoric acid n. 氢氟酸hydrogen embrittlement(钢的)氢脆* hydrogen n. 氢H* hydrogenation n. 加氢(作用)hydrolysate n. 水解产物* hydrolysis n. 水解(作用),加水分解hydroprocess n. 加氢过程* hydrostatics n. 流体静力学hydrostatic head 静水压头* hydroxide n. 氢氧化物* hydroxy(l) n. 羟基hyperoxide n. 过氧化物hypochlorite n. 次氯酸盐* hypothesis n. (pl. hypotheses) 假定,假说,前提hypothetical a. 假定[设,说]的,有前提的-ic anhydride 酸酐immerse vt. 浸(入,没),沉入;专心,埋头于,投入* immiscible a. 不混溶的,不互溶的* immobile phase 固定相immobile a. 固定的,稳定的,静置的impenetrate v. 渗透,贯通,深入* impermeable a. 不能透过的,不可渗透的,不透水的impingement n. (气体等的)撞击;水捶implement vt.实现,完成,履行impregnate v. 浸渍,注入,灌注 a. 浸透的,饱和的* impurity n. 杂质,夹杂物,污染物;不纯,污染in situ 就地,原地,在现场incentive a. 刺激的,鼓励的n. 刺激,诱因* incompressible a. 不可压缩性incondensable gas 不凝性气体incorporate v. 使结合,使合并;引入;体现induced draft fan 引风机inductive a. 引入的,导论的,诱导的* inert a. 惰性的,不活泼的;惯性的infinitesimal a. 无穷小的;细微末节的inflation n. 膨胀;通货膨胀* infrared a. 红外线的,红外区的* ingitability n. 可燃性,着火性* ingredient n.(混合物的)成分,组分,配料inherent a.固有的,生来的,内在的inhibit vi. 有禁止力,起抑制作用vt. 禁止;抑制,约束* inhibitor n. 抑制剂,抗氧化剂injection-moulding塑料注塑成型, 注模innovation n.创新,改革;新方法,新事物* inorganic a. 无机的,无机物的insecticide n. 杀虫剂,农药instrumental a. 有帮助的,起作用的;仪器的* insulation n. 绝缘,绝热;孤立,隔离* integrate vt. 使一体化,使结合;[数]求···的积分integrity n. 完整,完全,完善interfacial a. 界面的,面际的,层间的intermediate distillate中间馏分interplay n.;vi. 相互作用[影响],相互关系intrinsic a.内在的,固有的;本质的inventory n.库存量;(商品、物资等)清单invoice n. 发票,发货单,装货清单iodide n. 碘化物iodine n. 碘I* ion n. 离子ionize v. 使电离,离子化,游离(化)* irreversible process不可逆过程irrotational a. 无旋的,不旋转的i so- (相)等,(相)同的;(同分)异构isobaric a. 等压的isomerism n. 同分异构(现象)* isomerization n. 异构化(作用)isotherm n. 等温线* isothermal a.;n. 等温(的),等温线(的)isotope n. 同位素isotropic a. 各向同性的,均质的* jacket n. (汽、水)套,夹套kerosene n. 煤油,火油ketone n. (甲)酮kilocalorie n. 千(大)卡kilowatt n. 千瓦(特)* kinematics n. 运动学* kinetics n. 动力学* laminar a. 层流的,层状的laminate n. 层压制品[材料、塑料、板],a. 层状的,v. 层压,分层lanthanum n. 镧La* latent heat 潜热lateral a. 横向的,水平的lattice n. 晶格,点阵,格(栅,子,状)* leaching n. 浸取,浸提lead n. 铅Pbleaf filter 叶滤机leeway n. 余地,可允许的误差;落后legislation n.法规,立法liability n. 责任,义务ligarine n. 石油醚linear a. (直)线的,直线型的;线性的,线性化的* liquefaction n. 液化(作用)liquid-sealed a. 液封的lixiviate vt. 浸提[析,出],溶滤loop reactor 环路反应器lot n.(商品的)一批;批量;份额low-boiler n. 低沸化合物LPG = liquefied petroleum gas液化石油气lubricate vt. 使润滑* lubricating oil 润滑油macro- 宏(观),大(量),常量macromolecule n. 大分子,高分子macroscale n. 宏观尺度[刻度,标度]* macroscopic a. 宏观的;肉眼可见的magnesium n. 镁Mg* magnification n. 放大(倍数),倍率* magnitude n. (数)量级;大小mainstream n. 干流,主流;主要倾向manganese n. 锰Mnmanifold n. 总管,集气管,导管manipulate v. 操作,控制,运算manway n. 人孔mass separating agent质量分离剂mass spectrometry 质谱matrix n. 母体,基体,本体;[数]矩阵maturity n. 老化,陈化;成熟* maximize v. 使达到最大,使极大,极限化* mechanics n. 力学,机械学* mechanism n. 机理,机制,历程* membrane n. 膜,薄膜,隔板mercury n. 汞, 水银Hgmesh n. (筛)目[号],网(格,目)meso- 中(间,等,央),中等的;内消旋;介,新mesoscale n. 中间尺度[刻度,标度]meta-,m- 间(位)(有机系统名用);偏(无机酸用)metabolism n. (新陈)代谢(作用)metallurgy n. 冶金学,冶金术* metathesis n. 复分解(作用),置换(作用) methanation n. 甲烷化作用* methane n. 甲烷,沼气* methanol n. 甲醇* methyl n. 甲基micro- 微(量,型,观);显微;百万分之一microbe n. 微生物,细菌microelectronics n. 微电子学,微电子技术* microfiltration n. 微孔过滤micron n. 微米,10-6米;百万分之一microscale n. 微(观)尺度[刻度,标度]* microscopic a. 微观的,微小的;显微镜的* migrate v. 迁移,移动,流动mild steel 低碳钢,软钢mineral acid 无机酸* miscible a. 可互溶的,能溶合的mixed-phase reactor多相反应器* mixer-setller 混合澄清器* mobile phase 流动相* mockup n. 冷模,(1:1)的模型,同实物等大的研究用模型* modulus n. 模(数,量),系数,指数molybdenum n. 钼Mo* momentum n. 动量,冲量mono- 一,单一,单一的* monomer n. 单体,单聚物multiple effect evaporator多效蒸发器multiple-feed 多口进料multiply v. (使)增殖* multitude n.大批,大群,大量,众多* naphtha n. 石脑油,粗汽油,(粗)挥发油naphthalene n. 萘* naphthene n. 环烷烃* negligible a. 可忽略的,不计的,很小的* neutron n. 中子nickel n. 镍Ni* nitrogen n. 氮N* nitrate n. 硝酸盐[根,酯]nitration n. 硝化(作用),渗氮(法)* nitric acid n. 硝酸-nitrile 腈nitro- 硝基nitrogenous a. 含氮的* nomenclature n. 术语,命名(法),名称,(某一学科的)术语表nona- 九,壬nonane n. 壬烷* non-condensable gas不凝性气体* nonyl n. 壬基* nozzle n. 喷嘴nucleic acid 核酸* numerical a. 数(量,字,值)的,用数字表示的nutrient a. 营养的n. 营养基,营养素nylon n. 酰胺纤维,尼龙,耐纶obliterate vt. 除去,删去,消除octa- 八;辛octane rating 辛烷值octane n. (正)辛烷,辛烷值*octyl n. 辛基* offgas n.废气,气态废物* offset n. vt. 补偿,弥补,抵销off-the-shelf a. 成品的,现成的-oic acid 酸-ol 醇* olefin n.(链)烯(烃),烯族烃oleum n. 发烟硫酸-one 酮* one-pass 单程,非循环过程on-line 联机,在线,机内on-site a. (在)现场的,就地的opaque a. 不透明的;不传导的;无光泽的* operability n. (可)操作性[度]* optimize v.(使)最优[佳]化,优选* optimum a.;n. 最佳(的,点,值),最优(的,值)ordered packing 整砌填料,规整填料organofluorine compound n. 有机氟化合物* orifice n. 孔板;锐孔orth-,o- 邻位,正,原* osmosis n. 渗透(性,作用)* overflow v.溢出,溢流overhead n. 企业一般管理费;塔顶馏出物* overlap n.重迭(部分)* oxidation n. 氧化[反应,作用]* oxide n. 氧化物oxidize vt. 使氧化oxo- 氧代* oxygen n. 氧Oozonation n. 臭氧化作用* ozone n. 臭氧* packed tower 填充塔,填料塔palladium n. 钯Pdpara-,p- (位次)对位;仲;副* paraffin n. 链烷(属)烃,石蜡* parameter n. 参数,系数particulate a. 颗粒的,微粒的n.颗粒,微粒,粒子* patent n. 专利,专利权vt. 取得···的专利权pelletize v. 造粒,做成丸[球, 片]状penta- 五,戊pentane n. (正)戊烷* pentyl n. 戊基perforate v. 打孔,穿孔peripheral a.周边的,周围的,边缘的* peroxide n. 过氧化物* pesticide n.农药,杀虫剂* petrochemical a. 石油化学的n. 石油化学制品pharmaceutical n. 药物[品, 剂] a. 医药的,制药的,药物的phenol n. (苯)酚,石碳酸phenol-formaldehyde resin酚醛树脂* phenyl n. 苯基* phosphate n. 磷酸盐[酯],磷肥* phosphoric acid n. 磷酸* phosphorus n. 磷P,磷光体;启明星,金星photosynthesis n. 光合作用physical vapor deposition物理气相淀积pigment n. 颜料,色料;色素* pilot-plant n.中间(试验性)工厂,试验生产装置plasticizer n. 增塑剂plate and frame press板框式压滤机* plate tower 板式塔platinum n. 铂Pt, 白金* plug flow 活塞流, 平推流plutonium n. 钚Pupneumatic a. 气力的,气动的polarography n. 极谱法* poly vinyl chloride聚氯乙烯poly- 多,聚,重,复polyester n. 聚酯* polyethylene n. 聚乙烯* polymer n. 聚合物[体],高[多]聚物polymerization n. 聚合(反应,作用)polypropylene n. 聚丙烯polysaccharide n. 多糖polystyrene n. 聚苯乙烯polytetrafluoroethylene n. 聚四氟乙烯polythene n. 聚乙烯(=polyethylene) pore n. 细[毛,微,气]孔,孔隙* porous a. 多孔的,疏松的;能渗透的potassium n. 钾Kpotential flow 势流* potential n. 势(能),位(能),电势(位,压)pottery n. 陶器* precipitate n. 沉淀物,沉积物v. 使沉淀(出),析出precursor n. 产物母体, 前身, 先驱predominate vi. 占优势,居支配地位prefractionator n. 初步分馏塔premium n. 额外费用;奖励,奖金preparative chromatography制备色谱法* pressure drop 压降probe v. 试探,探测;(用探针,探测器)探查propagation n. 增长, 繁殖, 传播, 波及propane n. 丙烷propanol n. 丙醇propeller n. 螺旋桨,推进器propene n. 丙烯* proprietary a. 专利的,专有的,有专利权的n. 所有权,业主* propyl n. 丙基propylene n. 丙烯* protein n. 蛋白质,朊protocol n. (条约等的)草案,会谈备忘录,(外交)协定书* proton n. 质子protonate v. 使质子化pulsed column 脉冲塔pulverize vt. 使成粉末,研磨,粉碎* purge gas 吹扫气体* purification n. 净化,提纯purity n.纯度,品位;纯净,洁净;纯化PVC = poly vinyl chloride n. 聚氯乙烯* pyrolysis n. 热解(作用),高温分解pyrolyze vt. 热(分)解* qualitative a. 定性的;质的,质量的;性质上的qualitatively ad. 定性地* quantitative a. 定量的;数量的quantitatively ad. 定量地* quantum n. 量子quartz n. 石英,水晶* quench v.; n. 急冷,淬冷* radial a. 径向的,(沿)半径的radiator n. 辐射体,散热器,暖气装置* radical n. 基,原子团;根部;根式radium n. 镭Ra* raffinate n. 萃余液* random a. 随机的,无规则的,偶然的rate v. (对...)评价,估计,估价,计算* reactant n.反应物reaction injection moulding反应注射成型reactive a. 反应性的,活性的;反应的* reactivity n. 反应性,反应活性;反应* reactor n.反应器,反应堆* reagent n. 试剂,反应物* reboiler n. 再沸器rectangular a. 矩形的,长方形的rectifier n. 精馏器[塔];整流器rectify vt. 精馏,精炼,蒸馏rectifying section 精馏段* redox = reduction-oxidation n. 氧化还原(作用)redox petential 氧化还原电势* reduce v.(使)还原;减少* reduction n. 还原* refinery n. 炼油厂,提炼厂* reflux n. 回流,倒流reformate n. (汽油)重整产品* reforming n. 重整;转化refract v. 折射* refractory a. 难熔的,耐火的n. 耐火材料* refrigerant n.致冷剂,冷冻剂* regeneration n.再生,更新,新生regress vi. ;n. 回归* relative volatility相对挥发度(性)relevance n. 关联,关系;适当,贴切,中肯render v. 使得,使变为;提炼,提取* repel v.排斥,推开,击退,弹回replicate vt. 复制* reproducibility n. 再生性, 还原性,重复性* residence time 停留时间* residue n. 残余物,残渣,剩余物* resin n. 树脂vt. 用树脂处理retardation time 保留时间retort n. 蒸馏釜, 甑retrieval n. (数据,信息)检索* reverse osmosis 反渗透* reversible a. 可逆的,双向的revise vt. 修正,修改,校正revolve v. (使)绕[旋]转;循环;思索,反复思考rinse vt.;n. 漂洗,淋洗,清洗* riser n. 立(式)管(道),升气管rising film evaporator升膜式蒸发器rotary dryer旋转干燥器round-the-clock 连续一整天(或一昼夜)run-off n. 流出,流泻,径流;流量* rupture disk 安全(隔)膜rupture n.;v.破裂,断裂,破损saccharide n. 糖类,糖化物saponification n. 皂化(作用)* saturate v.使饱和;浸透 a.饱和的* scalar n. 标量,纯量* scale-up n.(按比例)放大,增加,升高schematically ad. 用示意图,用图解法,示意地,大略地* screen v. 筛分,筛选;屏蔽,隐藏scrub v. 气体洗涤,涤气,洗涤,清洗secondary reformer二段(次)转化炉(器)secondary,sec- 仲[指CH3···CH(CH3)-型支链烃,或指二元胺及R2CHOH型的醇]sediment n. 沉积物;沉积,沉淀* sedimentation n. 沉积,沉淀,沉降,淀积segment n. 部分;切片segregation n. 分离,分凝,分开* selectivity n. 选择性,选择seminar n.研究班,(专家)研讨班,讨论会semipermeable a. 半渗透性的semi-technical n. 半工业化的* sensible heat n. 显热sensing device 传感装置[器],遥感装置* sensitivity n. 灵敏性,灵敏度sensor n. 传感器,探测器serviceability n. 使用中的可靠性,耐用性* settling n. 沉降,沉淀sewage n. 污水,下水道(系统)shaft n. (传动,旋转)轴* shear stress 剪应力* shell and tube heat exchanger管壳式换热器,列管式换热器shift reaction 变换反应,转移反应* shortcut n. 近路,捷径v. 简化* shutdown n. 停工,停车,停止运转side-rectifier 侧线(馏分)精馏塔sidestream n. 侧线馏分,塔侧抽出物side-stripper 侧线(馏分)汽提塔* sieve plate 筛板(塔)sieve n. 筛,筛子;滤网vt.筛分,过筛,过滤silica n. 二氧化硅,硅石* silica-gel (氧化)硅胶silicate n. 硅酸盐[酯]silicon n. 硅Sisilver n. 银Ag* similarity n. 相似性,类似,相象* simulate vt. 模拟,仿真,模型化,模型试验simultaneously ad. 同时地;同时发生地single effect evaporator单效蒸发器size vt. 依一定尺寸制造,定尺寸,估计大小sketch n.示意图,简图,设计图sludge n. 淤泥,泥状沉积物;淤渣* slurry n. 稀浆,淤浆;悬浮液[体] soak up 吸收soda n.苏打,纯碱,碳酸钠;碳酸氢钠,小苏打soda-ash n. 纯碱,无水碳酸钠,苏打灰sodium dichromate n. 重铬酸钾* sodium n. 钠Nasoftware n. 软件,程序,程序计算方法;设计计算方法* solubility product 溶度积* solubility n. 溶解度,溶解性* solute n. 溶质,溶解物solution polymerization溶液聚合solvability n. 溶解[溶剂化]能力,可溶解性* solvent n.溶剂,溶媒sorbent n. 吸附剂,吸收剂* spare part n. 备件speciality n. 特制品,特殊产品;专门化,专业(化)* specification n.说明书;(pl.)(尺寸)规格,技术要求;明细表spectroscopic a. 用分光镜的,光谱(学)的* spectroscopy n. 光谱学* spectrum n.(光,波,能,质)谱,频谱;范围,领域spin off n. 伴随[附带] 的结果,有用的副产品spiral a. 螺旋(形)的,螺线的splitting n. 分解,分裂,蜕变* spontaneous a. 自发的,自然的spray dryer 喷雾干燥器stack gas 烟道气stagnant a. 滞流的,停滞的* stainless a.不锈的;纯洁的* standby a. 备用的,后备的n. 备用设备starch n. 淀粉,浆(糊)* startup n. 开动,运转* stationary phase 固定相stationary a. 静止的,固定的,不变的stearic acid 硬脂酸,十八(碳)(烷)酸* stereochemical a. 立体化学的sterile a. 无菌的,消过毒的sterilization n. 消毒,灭菌stiffness n. 刚性[度], 韧性* still n. 蒸馏釜,蒸馏stimulus n. 刺激,促进因素stirred tank reactor搅拌釜式反应器* stoichiometry n. 化学计算,化学计量,理想配比法straight run gasoline直馏汽油stripper n. 汽提塔, 解吸塔* stripping section 提馏段stripping n.汽提,解吸,洗提structured packing 结构填料* styrene n. 苯乙烯* subject-matter 主题,题材,要点,内容* sublimate v. 升华substrate n. 培养基,被酶作用物,基质sucrose n. 蔗糖,砂糖* suction n. 抽吸suffice vi. 足够,有能力vt. 满足(···的需要)* sulfate n. 硫酸盐[酯]* sulfide n. 硫化物sulfite n. 亚硫酸盐[酯]sulfo- 磺基* sulphate n. 硫酸盐[酯]sulphite n. 亚硫酸盐(酯)sulphonate n. 磺酸盐,磺化vt. 使磺化* sulphur n. 硫S, 硫磺* sulphuric acid 硫酸supercritical gas extraction超临界气体萃取* supercritical a. 超临界的* supersaturation n. 过饱和现象supervision n.监督,管理* surface-active agent 表面活性剂surfactant n. 表面活性剂suspension polymerization悬浮聚合* sustainable a. 可持续的,能支撑住的symposium n. 专题讨论会;论文集* syngas n. 合成气tailor-made a. 特制的,专用的,定做的;合适的,恰到好处的tangentially ad. 成切线teamwork n. 协力,协作,配合,协同作战teflon n.(商品名)特氟隆,聚四氟乙烯* tension n. 张力,弹力* terminology n.术语,专门用语tert- 叔tetra- 四,丁tetra-alkyl lead 四烷基铅the lion’s share 较大部分,最大部分thermal tubular reactor热管反应器* thermal a. 热(量,力)的,温的thermochemical a 热化学的thermocouple n. 热电偶* thermodynamics n. 热力学* thermoplastic n. 热塑性塑料 a. 热塑性的* thermoset n. 热固性 a. 热固性的thio- 硫代thorium n. 钍Ththoroughness n. 彻底性,充分性,完全性* throughput n.生产量,生产率,生产能力tin n. 锡Sntitanium n. 钛Ti* titrate v. 滴定n. 被滴定液TM =trademark n.商标* toluene n. 甲苯* toxic a. (有)毒的,毒性的n.毒药[物,剂]toxicity n. 毒性,毒力trade-off n. (对不能同时兼顾的因素的)权衡,比较评定,放弃trans- 反式;超,过* transition n. 过渡(段),转变,变化* transparent a. 透明的,半透明的,某种辐射线可以透过的tri- 三(重,倍,回)trickle bed reactor滴流床反应器tube sheet 管板tubular fixed-bed reaction管式固定床反应器* tubular reactor 管式反应器* tubular a. 管的,管式的,由管构成的tungsten n. 钨Wturbine n. 透平(机),叶轮机,汽轮机,涡轮(机)* turbulent a. 湍流的,紊流的;扰动的* turn-down ratio 极限负荷比,操作弹性* ultimated load 最大载荷ultracentrifuge n. 超速离心机* ultrafiltration n. 超滤(作用)ultra-red a. 红外的* ultraviolet a. 紫外的,紫外线的n. 紫外线unaccepted product 不合格(产)品* unbound electron 自由电子* underlie v. 构成[作为]···的基础;位于···的下面* unit operation 单元操作unlagged a. 未保温的,未隔热的;未绝缘的,* unsaturated a. 不饱和的update v. 适时修正,不断改进,使···适合新的要求uptake n. 吸收;领会,理解uranium n. 铀U* urea n. 尿素,脲valcanize n. 硫化,硬化* valence n.(化合)价,(原子)价validity n. 有效,合法性;正确,确实valve plate 浮阀塔(板)* valve n.阀,活门vanadium n. 钒V* vaporize vt.(使)汽化,(使)蒸发* vector n. 矢量,向量* ventilate vt. 通风,排气,开气孔,装以通风设备* venturi n. 文氏管verification n. 检验,验证* versatile a. 通用的,万能的;活动的,万向的via prep. [拉丁语] 经(过),viable a. 可行的,可用的;有生命力的,富有生命的* vinyl n. 乙烯基,乙烯树脂* viscosity n. 粘度,粘性* viscous a. 粘(性,滞,稠)的,* void fraction 空隙率void n. 空隙,空隙率* volatile a. 易挥发的,挥发性的* volatility n. 挥发度,挥发性vortex n. 旋涡;涡流(面),涡旋(体)vulcanization n. 硫化,硬化* weir n. 堰,溢流堰whizzer n. 离心机wiped-film evaporator刮膜式蒸发器xylene n. 二甲苯yeast n. 酵母-yl 基-yne 炔zeolite n. 沸石zinc n. 锌Zn。

医学专业英语词汇:常用抗菌药物的英文翻译

医学专业英语词汇:常用抗菌药物的英文翻译

医学专业英语词汇:常用抗菌药物的英文翻译医学专业英语词汇:常用抗菌药物的英文翻译导语:抗菌药物一般是指具有杀菌或抑菌活性的药物,包括各种抗生素、磺胺类、咪唑类、硝基咪唑类、喹诺酮类等化学合成药物。

下面cnfla小编为您收集整理了常用抗菌药物的'英文翻译,希望对您有帮助!常用抗菌药物的词汇一:氨基糖甙类链霉素 Streptomycin RIMACTANE, RIFAMPINN, ovostrep庆大霉素 Gentamycin 庆大霉素C,瑞贝克,正泰霉素庆大霉素链 Gentamicin Chains 塞透派勒链, Septopal妥布霉素Tobramycin 立可信软膏,点必舒眼药水(妥布+地塞米松)泰星,妥布拉霉素,托普霉素,NEBCIN,Factorb,Brulamycin, T obra, Nebramycin, Gernebcin, Obracine 小诺霉素Micronomicin 小诺米星,沙加霉素,相模霉素,Sagamicin, Kw-1062, MCR核糖霉素Ribostamycin 威他霉素,维生霉素,Vistamycin,Ibistacin大观霉素 Spectinomycin 奇霉素,壮观霉素,淋必治,奈毒素,Spectram,克淋, Trobicin, Kirin阿米卡星 Amikacin 丁胺卡那霉素, Amikin, Likacin西索米星 Sisomicin 西梭霉素,西索霉素,紫苏霉素, Sisomin,Sipeptin奈替米星 Netilmicin 乙基西梭霉素,奈特,奈替霉素,乙基西素米星,立克菌星,乙基紫苏毒素,Ethylsisomicin,Vectacin,Zetamicn, Certomycin, NETROMYCIN异帕米星 Isepamicin 依克沙霉素, HAPA-B, Exacin 医.学教育网整理阿司米星 Astromicin 阿司霉素,福提霉素,武夷霉素,强壮霉素FORTIMICIN, Kw-1070, ASTM, Fortimicin地贝卡星 Dibekacin 双去氧卡那霉素B, Dideoxykanamycin B,DKB,达苄霉素, Icacine依替米星 Etimicin 悉能常用抗菌药物的词汇二:磷霉素类磷霉素 Fosfomycin 福赐美仙, Phosphonomycin, Fosfocina,FOM磷霉素氨基丁三醇 Fosfomycin Tromethamine Monurol常用抗菌药物的词汇三:青霉素类青霉素(G) Penicillin(G) Benzylpenicillin,苄青霉素,盘尼西林青霉素V Penicillin V Phenoxymethylpenicillin,Blinvan,Ospen,苯氧甲基青霉素苄星青霉素 Benzathine Penicillin 长效西林,长效青霉素,比西林, LPG,苄星青氨苄西林 Ampicillin 安比西林,氨苄青霉素,安必仙,安必林,安比林阿莫西林 Amoxicillin 特力士,弗来莫星,羟氨苄青霉素,益萨林,阿莫仙,安福喜,本原莫星巴氨西林 Bacampicillin 美洛平,氨卡西林,氨苄青霉素甲戊酯阿洛西林 Azlocillin 阿乐欣,咪氨苄西林,氧咪苄青霉素, Azlin 美洛西林 Mezlocillin 天林, Baypen, Mezlin, Baycipen替卡西林Ticarcillin 羧噻吩青霉素,的卡西林,Nonapen,Ticarpen酞氨西林Talampicillin 氨苄青霉素酞酯,酞氨苄青霉素,酞氨苄西林, TAPC, Talpen夫苄西林 Furbenicillin 呋脲苄青霉素,呋苄青霉素,呋氨西林,呋喃酰脲苄青霉素氟氯西林Flucloxacillin 氟氯苯唑青霉素,氟沙星,福氯平,Floxapen羧苄西林 Carbenicillin 羧苄青霉素,卡比西林,羧苄青阿扑西林 Aspoxicillim 天冬羟氨青霉素, Doyle, ASPC匹氨西林 Pivampicillin 氨苄西林酯,匹凡西林,匹呋西林,吡呋氨卡西林双氯西林Dicloxacillin 双氯青,Dynapen,Consaphyl,Stampen, Diflor甲氧西林 Meticillin 新青霉素Ⅰ,美替西林, Azapen, Penysol 苯唑西林钠 Oxacillin Sodium 新青霉素Ⅱ,苯唑青霉素钠,苯甲异噁唑青霉素奈夫西林 Nafcillin 新青霉素Ⅲ,乙氧萘青霉素匹美西林Pivmecillinam 氮卓咪青霉素双酯,Celfuron,Melysin仑氨苄西林 Lenampicillin Varacillin, Takacillin美西林Mecillinam Selexidleo,Selexid,Coactin,Amdinocillin,氮卓脒青霉素哌拉西林钠 Piperacillin Sodium 氧哌嗪青霉素,哔哌西林,哌氨苄青霉素Avocin, Orocin, Pipril氯唑西林钠Cloxacillin Sodium 邻氯青霉素钠,氯唑青,Orbenin阿帕西林钠 Apalcillin Sodium 萘啶青霉素钠, APPC, Lumota,Elumota, Palcin磺苄西林钠 Sulbenicillin Sodium 磺苄青霉素钠,卡他西林,格达西林Sulfocillin, Lilacillin, Kedacillin青霉素V钾Phenoxymethylpenicillin Potassiume 6–苯氧乙酰胺基青霉烷酸钾,Cillaphen Distaquaine VK,Compocillin VK,Dowpen VK Cilicaine VK, Apopen, Biopen海他西林钾Hetacillin Potassium 缩酮氨苄青霉素钾,Etacillin,Veisapen卡茚西林钠 Carindacillin Sodium Carbenicillin Indanyl Sodium,Geopen, Geocillin治平霉素替莫西林二钠 Temocillin Disodium Temopen常用抗菌药物的词汇四:头孢菌素类第一代头孢噻吩钠 Cefalotin Sodium 先锋Ⅰ号,头孢金素,噻孢霉素,CET头孢噻啶 Cefaloridine 先锋Ⅱ号,头孢利素, CER, Kafspor头孢来星Cefaloglycine 先锋Ⅲ号,头孢甘酸,Kafocin,Kefglycin头孢氨苄 Cefalexin 先锋Ⅳ号,苯甘孢霉素,头孢力新, CEX头孢唑啉钠 Cefazolin Sodium 先锋Ⅴ号,塞福宁,西华乐林,先锋啉,凯复唑Cefalin, CEX, Cefamedin, Kefzol, Cramaxin 头孢拉定Cefradine 先锋Ⅵ号,头孢雷定,头孢瑞丁,头孢环已烯,泛捷复, Velosef, CED,塞福定头孢乙腈 Cefacetrile 先锋Ⅶ号,头孢腈甲,头孢赛曲头孢匹林 Cefapirin 先锋Ⅷ号,头孢吡硫, Ceta-Dri头孢硫脒 Cefathiamidine 先锋18,吡脒头孢头孢克洛 Cefaclor 赐福乐素,新达乐,头孢氯氨苄, Ceclor,希刻劳,头孢克罗,可福乐,氯头孢菌素, CCL头孢羟氨苄Cefadroxil Cefadril,Kefroxil,羟氨苄头孢菌素,欧意, CDX,Duracef, Bidocef, Cefamx头孢沙定 Cefroxadine 头孢环烯氨, ORASPON, CGP-9000,CXD头孢罗齐 Cefprozil 头孢丙烯, Cefzil头孢替唑 Ceftezole 特子社复, Tezacef, Alomen第二代头孢呋辛钠 Cefuroxime Sodium 头孢呋肟,赐福乐信,舒贝洛,西力欣,特力欣,明可欣, CXM, Zinacef, Monacef, Ketocef,Furex Kesiut, Supero头孢替安 Cefotiam 噻乙胺唑头孢菌素,头孢噻乙胺唑,泛司博林,泛司颇灵, Pansparin, Halospor, CTM头孢呋辛酯 Cefuroxime Axetil 头孢呋肟酯,新菌灵,西力达,头孢呋新乙酰乙酯Zinnat头孢西丁 Cefoxitin 头孢氧唑,甲氧头霉噻吩,噻吩甲氧头孢菌素,美福仙,甲氧头霉噻吩, CXT, CFX头孢尼西二钠Cefonicid Disodium 铭乐希,Monocid,Cefonicid, Cefodie, Cefol头孢孟多Cefamandole 头孢羟唑,羟苄四唑头孢菌素,Mandolkef, CMT, Cefadole, Mandol头孢美唑钠 Cefmetazole Sodium 先锋美他醇,氰唑甲氧头孢菌素,头孢氰四唑,头孢美他唑, CEFMETAZON, CMZ, Cemetol 头孢布宗 Cefbuperazone 头孢拉宗, Keiperazon, Tomiporan,Cefobutazine, CBPZ头孢雷特 Ceforanide 头孢氨甲苯唑,头孢苄胺四唑,氨苄唑头孢菌素Precef第三代头孢地尼 Cefdinir Cefzon头孢布坦 Ceftibuten 头孢布烯, Cedax头孢卡品 Cefcapene Pivoxil 头孢卡喷新戊酰氧甲酯, Flomox头孢噻肟钠 Cefotaxime Sodium 头孢氨噻肟,泰可欣,塞福隆,菌必灭,治菌必妥,凯福隆,凯复龙,头孢噻肟,喜福得,Claforan, CTX头孢曲松钠 Ceftriaxone Sodium 头孢三嗪,头孢泰克松,罗氏芬,罗噻嗪,菌必治,菌得治,头孢三嗪噻肟,泛生舒复,西华瑞隆, Rocephin, Ro-139904, CTRX头孢哌酮钠 Cefoperazone Sodium 头孢氧哌唑,先锋必,头孢必,达诺欣,塞福必,Cefobid, T-1551, CPZ头孢他啶Ceftazidime 头孢塔齐定,头孢羧甲噻肟,复达欣,凯复定,Glazidine,Fortaz,Eposerin,Modocin,Fotrum,Tazidime, CTZ, Spectrum, Eposerin, Modocin头孢唑肟Ceftizoxime 头孢去甲噻肟,益保世灵,安保速灵,Epocelin CZX, CEFTIZOX头孢克肟 Cefixime 头孢烯噻羟肟,世伏素,世福素, FK027,Suprax, CFIX , CEFSPAN头孢甲肟 Cefmenoxime 头孢氨噻肟唑,倍司特克, BESTCALL,CMX头孢地嗪Cefodizime 头孢双唑,莫敌,莫敌威,Modivid,Timcef头孢匹胺 Cefpiramide 先福吡兰,甲吡唑头孢菌素,头孢吡胺,CPM,Cefpiran, Sepatren头孢特仑酯 Cefteram Pivoxil 头孢特仑新戊酰氧甲酯,托米仑,头孢他美酯,富山龙, Tomiron头孢磺吡苄钠Cefsulodin Sodium 头孢磺吡酮,头孢磺啶钠,磺吡苄头孢菌素钠,达克舒林,Cefsulodine,Takesulin,CFS,SCE129拉他头孢Latamoxef 羟羧氧酰胺菌素,拉氧头孢,头孢拉坦,噻吗灵Moxalactam, Shiomarin, Moxam, LMOX头孢米诺 Cefminox 氨羧甲氧头孢菌素,美土灵, Meicelin头孢咪唑 Cefpimizole Benilan, SPIE, Ajicef头孢替坦二钠Cefotetan Disodium 双硫唑甲氧头孢霉素,Yamatetan, CTT, Cefotan第四代头孢唑喃钠 Cefuzonam Sodium Cosmosin, CZON氟氧头孢钠 Flomoxef Sodium 氟莫克西, 6315-S头孢匹罗 Cefpirome 头孢吡隆,氨噻肟吡戊头孢常用抗菌药物的词汇五:其它Β-内酰胺类亚胺培南 Imipenem 伊米配能,亚胺硫霉素, NFT氯曲南Aztreonam 菌克单,君刻单,噻肟单酰胺菌素,AZACTAM,Primbactam, Primbactin, SQ-26776氟罗培南 Faropenem 福劳派南, Farom苄西林/氯唑西林Ampicillin/Cloxacillin 复方安比西林,爱罗苏,氨氯西林,白罗仙,淋必清, Pinocine亚胺培南/西司他丁Imipenem/Cilastatin 亚胺硫霉素/西拉司丁,泰能, TIENAM, PRIMAXIN阿莫西林/氟氯西林Amoxicillin/Flucloxacillin 氟羟西林,新灭菌, Biflocin, Infectrin三羟阿莫西林/单羟双氯西林Amoxycillin Trihydrate/Dicloxacillin康彼身,克菌, CompliscanΒ-内酰胺类抗生类+Β-内酰胺酶抑制剂氨苄西林/舒巴坦 Ampicillin/Sulbactam 强力安必仙,舒他西林,优力新,新凯兰欣,舒氨欣, Unasyn, Sultamicillin头孢哌酮/舒巴坦 Cefoperazone/Sulbactam 舒普深,舒哌酮,Sulperazone头孢噻肟/舒巴坦 Cefotaxime/Sulbactam 新治菌哌拉西林/他佐巴坦 Piperacillin/Tazobactam Tazocin, YP-14阿莫西林/克拉维酸 Amoxillin/Clavulanic Acid 安灭菌,安美汀,奥格门汀,安美汀,阿莫克拉Augmentin, BRL25000替卡西林/克拉维酸 Ticarcillin/Clavulanic Acid 泰门汀,特泯菌,特美汀, Timentin舒巴坦 Sulbactam 舒巴克坦,陪他美,青霉烷砜。

药品稳定性试验箱维护保养计划

药品稳定性试验箱维护保养计划

药品稳定性试验箱维护保养计划英文回答:Maintenance and upkeep are essential for ensuring the stability testing chamber's optimal performance and longevity. Regular maintenance not only extends thelifespan of the equipment but also ensures accurate and reliable test results. In this maintenance plan, I will outline the key tasks and frequency for maintaining and servicing the stability testing chamber.Firstly, it is crucial to regularly clean the stability testing chamber to prevent the buildup of dust, debris, and contaminants. This can be done by wiping down the interior and exterior surfaces with a mild detergent solution and a non-abrasive cloth. Additionally, the filters should be inspected and cleaned or replaced if necessary to maintain proper air circulation within the chamber.Secondly, calibration is a critical aspect ofmaintaining the stability testing chamber's accuracy. The temperature and humidity sensors should be calibrated at regular intervals to ensure precise and consistent readings. This can be done by comparing the chamber's readings with a calibrated reference thermometer and hygrometer. If any discrepancies are found, adjustments or repairs should be made promptly.Furthermore, it is essential to inspect and maintainthe chamber's electrical components. This includes checking the power supply, wiring, and connections for any signs of damage or wear. Loose connections should be tightened, and any faulty components should be replaced to preventelectrical malfunctions that could affect the stability testing process.In addition to regular maintenance tasks, it is also important to perform periodic performance qualifications to verify the stability testing chamber's functionality. This involves conducting temperature and humidity mappingstudies to ensure uniformity and stability within the chamber. Any deviations or inconsistencies should beaddressed and resolved promptly to maintain the chamber's reliability.Moreover, it is advisable to keep a record of all maintenance activities, including cleaning, calibration, and repairs. This documentation serves as a reference for future maintenance and provides a history of the chamber's performance. It is also beneficial for audits and regulatory inspections, demonstrating that the stability testing chamber is properly maintained and operated.To illustrate the importance of maintenance and upkeep, let's consider an example. Suppose a stability testing chamber is not regularly cleaned, resulting in the accumulation of dust and debris on the sensors and filters. This can lead to inaccurate temperature and humidity readings and compromised test results. Additionally, if the electrical components are not inspected and maintained, there is a higher risk of electrical failures that could disrupt the stability testing process. By adhering to a comprehensive maintenance plan, these issues can be prevented, ensuring the stability testing chamber's optimalperformance and reliability.中文回答:维护保养对于确保药品稳定性试验箱的最佳性能和使用寿命至关重要。

新辅助化疗后乳腺病理学完全缓解患者可以避免腋窝手术

新辅助化疗后乳腺病理学完全缓解患者可以避免腋窝手术

新辅助化疗后乳腺病理学完全缓解患者可以避免腋窝手术病理学完全缓解(pCR:无浸润或原位癌)可见于40%~50%的HER2阳性和三阴性乳腺癌患者。

新辅助化疗后乳腺经皮活检表明乳腺pCR的手术必要性受到质疑。

此前,尚不明确新辅助化疗后乳腺pCR 患者的腋窝转移风险有多大?对于此类患者的腋窝应该如何适当处理?可否避免手术?2017年4月19日,《美国医学会杂志外科学分册》在线发表德克萨斯大学MD安德森癌症中心的队列研究报告,发现对新辅助化疗pCR的乳腺癌患者腋窝转移风险极低而可避免手术。

•MD安德森癌症中心:创建于1941年,1971年美国《国家癌症法案》最早指定的的3个综合癌症中心之一,以美国银行家和世界最大棉花商、门罗·邓纳维·安德森(Monroe Dunaway Anderson)命名,位于德克萨斯州休斯敦的德克萨斯医学中心,为德克萨斯大学附属医院,是集肿瘤临床诊断、综合治疗、基础医学研究于一体的大型专科医院,在美国乃至全球皆享誉盛名,多次被评为美国最佳癌症研究机构,每年收治来自世界各地的10万余位患者,其中不乏各国政要和富商,包括阿拉伯联合酋长国现任总统哈利法·扎耶德。

2011年,为了感谢成功治愈,哈利法·扎耶德向该中心捐款1.5亿美元。

该单中心前瞻队列研究于2010年1月1日~2014年12月31日连续入组527例HER2阳性/三阴性(T1/T2和N0/N1)乳腺癌患者,中位年龄51岁(范围:23~84岁),新辅助化疗后进行标准的乳腺和淋巴结手术。

根据亚型、初始超声检查结果、淋巴结病理学情况,对乳腺pCR与否的患者进行比较。

计算患者的最终病理学评估淋巴结阳性率,并使用相对风险比和95%置信区间进行比较。

结果发现:•初始淋巴结超声检查显示N0病变患者290例,新辅助化疗后乳腺pCR者116例(40.4%),并且100%无腋窝淋巴结转移。

•初始淋巴结活检病理证实N1病变患者237例,新辅助化疗后乳腺pCR、未pCR者分别有77、160例,其中无残留淋巴结病变证据的患者分别有69、68例(89.6%、42.5%,P<0.01)。

剂型中英文对照

剂型中英文对照

1。

Adj:药用辅料(Pharmaceutic Adjuvant)稀释剂(Diluent Agent)黏合剂(Binder)崩解剂(Disintegrating Agent)润滑剂(Lubricant)基质(Base)芳香剂(Flavoring Agent)甜味剂(Sweetening Agent)着色剂(Coloring Agent)防腐剂(Preservative or Antiseptics)抗氧化剂(Antioxidant)包衣剂(Coating Materials)成膜材料(Film-Forming Materials)溶剂(Solvent)增溶剂(Solubilizer)润湿剂(Wetting Agent or Moistening Agent)吸附剂(Absorbent)助滤剂(Filtering Aid)乳化剂(Emulsifying Agent)表面活性剂(Surfactant)助悬剂(Suspending Agent)增稠剂(Viscosity Increasing Agent)增塑剂(Plasticizer)螯合剂(Chelating Agent)透皮促进剂(Transdermal Enhancer)气雾抛射剂(Aerosol Propellant)起泡剂(Foaming Agent)酸碱调节剂(Acidifying or Alkalizing Agent)缓冲剂(Buffering Agent)2。

Aer:气雾剂(Aerosol)吸入气雾剂(Inhalation Aerosol)吸入粉雾剂(Powder for Inhalation)非吸入气雾剂(Non—Inhalation Aerosol)非吸入粉雾剂(Non-Inhalation Aerosol Powder)外用气雾剂(Topical Aerosol, Skin Aerosol)喷雾剂(Spray)药用泡沫剂(Medicated Foam,Cutaneous Foam)鼻腔用喷雾剂(Nasal Spray)3。

医学英语单词表之心律失常与药物(三)

医学英语单词表之心律失常与药物(三)

医学英语单词表之心律失常与药物(三)医学英语单词表之心律失常与药物(三):
41. antidromic 逆行的
42. supraventricular 室上的
43. magnesium sulfate 硫酸镁
44. lodicaine 利多卡因
45. hypokalemia 低钾血症
46. quinidine 奎宁丁
47. Procainamide 普鲁卡因胺,普鲁卡因酰胺
48. disopyramide 丙吡胺
49. lidocaine 利多卡因
50. mexiletine 美西律(慢心律、脉律定)
51. tocainide 妥卡尼,氨酰甲苯胺
52. flecainide 氟卡胺
53. encainide 英卡胺;恩卡胺;恩卡尼
54. propafenone 丙胺苯丙酮
55. propranolol 心得安
56. esmolol 艾司洛尔,4-苯丙酸甲酯的盐酸盐
57. metoprolol 美托洛尔
58. atenolol 阿替洛尔,氨酰心安
59. timolol 噻吗洛尔
60. bretylium 溴苄胺
61. amiodarone 胺碘达隆
62. soatlol 甲磺胺心定,心得怡
63. verapamil 戊脉安,异搏定
64. diltiazem 地尔硫卓
65. toxicity 毒性,毒力
66. nausea 作呕;恶心;反胃;极度厌恶
67. vomiting 呕吐
68. diarrhea腹泻
69. ibutilide 伊布利特。

医院经常使用抗菌药物的英文翻译

医院经常使用抗菌药物的英文翻译

医院经常使用抗菌药物的英文翻译喹诺酮类第二代吡哌酸Pipemidic Acid PPA第三代诺氟沙星Nofloxacin 氟哌酸,淋克星,Fulgram,Noroxin,AM-715 MK-0366,Brazan,Baccidal 环丙沙星Ciprofloxacin 悉复欣,悉普欣,悉普宁,丽珠环丙,特美力,环丙氟哌酸,健宝灵,CIPRO,Bay-0-9867,Ciprobay,Ciproxin培氟沙星Pefloxacin 培福新,甲氟哌酸,倍泰,Peflacine洛美沙星Lomefloxacin 洛威,罗氟酸,欣美罗,多龙,Bareon芦氟沙星Rufloxacin 如氟沙星左旋氧氟沙星Levofloxacin 可乐必妥,左氟沙星,Cravit依诺沙星Enoxacin 氟啶酸,福禄马,复克,FLUMARK,GYRAMID,Flumark氟罗沙星Fleroxacin 复诺定,多氟哌酸,喹诺敌,麦加乐定,沃尔得FLX,Megelone,Quinodis,Ro-236240,AM-833氧氟沙星Ofloxacin 氟嗪酸,秦利必妥,泰利特,奥复星,康泰必妥,竹安新,TARIVID,赞诺欣,Zanoxin,Oflocin,泰利得,正康培氟沙星Pefloxacin 甲氟哌酸,培氟哌酸,培福新,倍宁,Pefalcine磺胺类柳氮磺胺吡啶Sulfasalazine SASP,水杨酰偶氮磺胺吡啶,Rorasul Salicylazosulfapyridine复方新诺明SMZ+TMP SMZ Co,Cotrim磺胺嘧啶Sulfadiazine 大安净,地亚净,磺胺哒嗪,SD磺胺甲噁唑Sulfamethoxazole 磺爱胺甲基异噁唑,新诺明,SMZ,SINOMIN 磺胺米隆Mafenide 甲磺灭脓,Sulfamylon,氯苄磺胺,SML磺胺嘧啶银Sulfadiazine Silver SD-Ag磺胺醋酰钠Sulfacetamide Sodium 碘胺乙酰,斑马眼药水,目宁,SA,SC-Na 磺胺脒Sulfaguanidine 磺胺胍,克痢定,消困定,止痢片,SG甲氧苄啶类甲氧苄啶Trimethoprim 甲氧苄氨嘧啶,美替普林,磺胺增效剂,TMP,三甲氧普林溴莫普林Brodimoprim Clafalix,BMP,Hyprim,溴莫卜宁大环内酯类红霉素Erythromycin 福爱力,Eryc,EM琥乙红霉素Erythromycin Ethylsucinate 琥珀酸乙酯红霉素,红霉素琥乙酯,乙琥威霉素,利尹沙依托红霉素Erytromycin Estolate 无味红霉素,Laurylin,Mistral,Eriscel阿红霉素Azitromycin 阿泽红霉素,阿奇霉素,氮红霉素,舒美特,希舒美,Sumamed白霉素Leucomycin 吉他霉素,阿波霉素,利可霉素,Kitasamycin,Yosaxin 罗红霉素Roxithromycin 欣美罗,罗力得,小儿罗立特,Rulid螺旋霉素Spiramycin 罗华密新乙酰螺旋霉素Acetylspiramycin AC-SPM交沙霉素Josamycin 交沙咪,角沙霉素,Josaxin麦迪霉素Midecamycin 麦地霉素,美地霉素,米地加霉素,Medemycin,美他霉素乙酰麦迪霉素Acetylmidecamycin 美欧卡霉素,醋酸麦迪霉素,Midecamycin,Acetate,Miocamycin,罗他霉素Rokitamycin 罗吉他霉素,利可霉素,Ricamycin甲红霉素Clarithromycin 克红霉素,克拉霉素,克拉仙,Klacid,Klaricid威毒素Erythromycin Base 红霉素碱,Wyamycin麦白霉素Meleumycin四环素类美他环素Methacycline 飞梭霉素,甲烯土霉素,甲烯环素米诺环素Minocycline 康尼,二甲胺四环素,美满霉素,二甲胺四环素,Vectrin,Minomax,Minocin,Ultramyin,四环素Tetracycline Copharlan,Telotrex,Tetramig金霉素Aureomycin Chlortetracycline土霉素Oxytetracycline 氧四环素,Copharoxy,Doxymycin,Imperacin,TERRAMYCIN多西环素Doxycyclme 强力霉素,脱氧土霉素,福多力,多喜霉素,Doryx,Vibramycin地美环素Demeclocycline 去甲金霉素,DMCT,Temet,Dimeral硝咪唑类甲硝唑Metronidazole 甲硝羟乙唑,灭滴灵,咪唑呢达,灭滴唑,佳尔钠FLAGYL,Klion,Arilin替硝唑Tinidazole 服净,Fasigyn氯霉素类氯霉素Chloramphenicol CHLOROMYCETIN无味氯霉素Chloramphenicol Palmitate 棕榈氯霉素琥珀氯霉素Chloramphenicol Succinate甲砜毒素Thiamphenicol硝基呋喃类呋喃妥因Nitrofurantoin 呋喃坦丁,呋喃坦啶,硝呋妥因,Cystit呋喃唑酮Furazolidone 痢特灵,Nifurazolidone,FUROXON,Trifurox硝呋太尔Nifuratel 硝呋拉太,呋喃硫唑酮,欧姆宁,Omnes多肽类Methylmercadone去甲万古霉素Norvancomycim万古霉素Vancomycin 稳可倍,凡可霉素,万古新,Vancoina,Diatracin,Vancor多粘菌素B Polymyxin B AEROSPORIN多粘菌素E Polymyxin E 粘菌素,抗敌素,可利迈仙,Colistin,Colimycine短杆菌肽Gramicidin 滴眼剂Neosporin抗结核病药异烟肼Isoniazid 雷米封,INH,Rimifon,Retozide,Zonazid乙胺丁醇Ethambutol EMB,Etambin,Myambutol对氨基水杨酸Paraminosalicylic Acid PAS,Teebacin Acid,Deapasil吡嗪酰胺Pyrazinamide 异烟酰胺,PZA,Pezetamid,Pyrafat利福霉素SV Rifamycin SV 羟基利福霉素,力复霉素,Rifocin,Rifocyn,Rifosten,利福定Rifandin 利康霉素,异丁基哌嗪力复霉素,Riconmycin利福喷丁Rifapentine 环戊去甲利福平,环戊基哌嗪力复霉素,RPE,Rifapentini 紫霉素Viomycin 结核放线菌素B,佛罗里霉素,Vinactane,Viocin利福平Rifampin 力复平,甲哌利福霉素,利米定,威福仙,RFP卷曲霉素Capreomycin 卷须霉素,缠霉素,结核霉素,CPC,CPM,CPR利福昔明Rifaximin 利福西亚胺,Rifaxidin,Normix乙硫异烟胺Ethionamide抗真菌药咪康唑Miconazole 达克宁,拜尼罗(康松无极膏),无霉,霉可唑,双氯苯咪唑,霉康唑,美康唑,密康唑,克霉灵Micotin,Daktar,Andergin,Monistat 益康唑Econazole 癣敌,氯苯咪唑硝酸盐,Ecostatin,Pevaryl,Pevary氟康唑Fluconazole 达扶康,麦道氟康,DIFLUCAN,Medoflucon酮康唑Ketoconazole 里素劳,皮康王,采乐,NIZORAL特康唑Terconazole 疗霉舒,三并萘芬,Lamisil伊曲康唑Itraconazole 伊他康唑,斯皮仁诺,伊康唑,IRC,R5121,Sporanox,亚特那唑硝酸芬替康唑Fenticonazole Nitrate Lomexin硝酸硫康唑Sulconazole Nitrate Exelderm,Sulcosyn,SCZ联苯苄唑Bifonazole 霉克,孚琪,白肤唑,必佛那唑,Mycosporan,Mycospor,Bifazole两性霉素B Amphotericin B灰黄霉素Grisefulvin Grivulfin制霉菌素Nystatin 米可定,Nysfungin,,Mycostatin复方康钠乐霜Kenacomb Co 金曲安缩松,制霉菌素,硫酸新霉素,短杆菌肽氟胞嘧啶Fluorocytosine 5-氟胞嘧啶,安确治,Ancotil,5-FC,Ancobon,Flucytosin环匹罗司Ciclopirox Olamine 巴特芬,环吡司胺,环吡酮胺美帕曲星Mepartricin 克霉灵,甲帕霉素,Montricin丙噻酯Protiofale Atrimycon依沙酰胺Exalamide 克癣安布特那芬Butenafine Hydrochloride Mentax特比萘芬Terbinafine Lamisil,SF86-327抗病毒药三氮核苷唑Ribavirin` 病毒唑,利巴韦林,尼斯可,VIRAZOLE无环鸟苷Acyclovir 阿昔洛韦,Zovirax,永信克疱,丽珠克毒星,舒维疗更昔洛韦Ganciclovir 丽科伟,鸟嘌异甘醚,DHPG,Cytovene因地那韦Indinavir Crixivan奈非那韦Nelfinavir Viracept利托那韦Ritonavir Norvir西道法韦Cidofovir Vistide,HPMPC喷昔洛韦Penciclovir Vectavir,PCV布昔洛韦Buciclovir DHBG,VIS-707喷昔洛韦Penciclovir法昔洛韦Famciclovir BRL39123万乃洛韦Valaciclovir 明竹欣,MAXVIR法莫丁Famotine 鼻通,氯苯氢异喹,抑感灵阿糖腺苷Vidarabine Vira-A,Ara-A,Panavirin齐多夫定Zidovudine 叠氮胸苷,Azidothymidine,AZT,RETROVIR 膦甲酸钠Foscarnet Sodium Foscavir,PFA,Terap甲磺酸地拉维定Delavirdine Mesylate Rescriptor吗啉胍Moroxydine ABOB,病毒灵,Bioxine碘苷Idoxuridine 碘甙,疱诊净,IDU,5-IDUR金刚烷胺Amantadine聚肌胞Poly-IC Polyinosinic-Polycytidylio Acid,PIC,聚肌胞苷酸干扰素Interferons IFN,Roferon-A,Berofor,Wellferon金刚乙胺Rimantadine Hydrochloride 三环癸胺,Roflual,Ioride林可霉素类克林霉素Clindamycim 氯林可霉素,特丽仙,克林美,氯洁霉素,林大霉素Cleocin,Dalacin林可霉素Lincomycin 洁霉素,林肯霉素植物药黄连素Berberine 小檗碱无味黄连素Berberine Tannate 鞣酸小檗碱板蓝根Isatis Tiactoria 大青叶穿心莲Andrographolide 一见喜,榄核莲,穿琥宁,穿心莲内酯,炎琥宁鱼腥草素Houttuynin 癸酰乙醛,合成鱼腥草素,Capryt Ethaldehyde大蒜素Allicin 阿里新,Aricine,大蒜辣素,蒜素青霉素类青霉素(G)Penicillin(G)Benzylpenicillin,苄青霉素,盘尼西林青霉素V Penicillin V Phenoxymethylpenicillin,Blinvan,Ospen,苯氧甲基青霉素苄星青霉素Benzathine Penicillin 长效西林,长效青霉素,比西林,LPG,苄星青氨苄西林Ampicillin 安比西林,氨苄青霉素,安必仙,安必林,安比林阿莫西林Amoxicillin 特力士,弗来莫星,羟氨苄青霉素,益萨林,阿莫仙,安福喜,本原莫星巴氨西林Bacampicillin 美洛平,氨卡西林,氨苄青霉素甲戊酯阿洛西林Azlocillin 阿乐欣,咪氨苄西林,氧咪苄青霉素,Azlin美洛西林Mezlocillin 天林,Baypen,Mezlin,Baycipen替卡西林Ticarcillin 羧噻吩青霉素,的卡西林,Nonapen,Ticarpen酞氨西林Talampicillin 氨苄青霉素酞酯,酞氨苄青霉素,酞氨苄西林,TAPC,Talpen夫苄西林Furbenicillin 呋脲苄青霉素,呋苄青霉素,呋氨西林,呋喃酰脲苄青霉素氟氯西林Flucloxacillin 氟氯苯唑青霉素,氟沙星,福氯平,Floxapen羧苄西林Carbenicillin 羧苄青霉素,卡比西林,羧苄青阿扑西林Aspoxicillim 天冬羟氨青霉素,Doyle,ASPC匹氨西林Pivampicillin 氨苄西林酯,匹凡西林,匹呋西林,吡呋氨卡西林双氯西林Dicloxacillin 双氯青,Dynapen,Consaphyl,Stampen,Diflor 甲氧西林Meticillin 新青霉素Ⅰ,美替西林,Azapen,Penysol苯唑西林钠Oxacillin Sodium 新青霉素Ⅱ,苯唑青霉素钠,苯甲异噁唑青霉素奈夫西林Nafcillin 新青霉素Ⅲ,乙氧萘青霉素匹美西林Pivmecillinam 氮卓咪青霉素双酯,Celfuron,Melysin仑氨苄西林Lenampicillin Varacillin,Takacillin美西林Mecillinam Selexidleo,Selexid,Coactin,Amdinocillin,氮卓脒青霉素哌拉西林钠Piperacillin Sodium 氧哌嗪青霉素,哔哌西林,哌氨苄青霉素Avocin,Orocin,Pipril氯唑西林钠Cloxacillin Sodium 邻氯青霉素钠,氯唑青,Orbenin阿帕西林钠Apalcillin Sodium 萘啶青霉素钠,APPC,Lumota,Elumota,Palcin 磺苄西林钠Sulbenicillin Sodium 磺苄青霉素钠,卡他西林,格达西林Sulfocillin,Lilacillin,Kedacillin青霉素V钾Phenoxymethylpenicillin Potassiume 6–苯氧乙酰胺基青霉烷酸钾,Cillaphen Distaquaine VK,Compocillin VK,Dowpen VK Cilicaine VK,Apopen,Biopen海他西林钾Hetacillin Potassium 缩酮氨苄青霉素钾,Etacillin,Veisapen卡茚西林钠Carindacillin Sodium Carbenicillin Indanyl Sodium,Geopen,Geocillin治平霉素替莫西林二钠Temocillin Disodium Temopen头孢菌素类第一代头孢噻吩钠Cefalotin Sodium 先锋Ⅰ号,头孢金素,噻孢霉素,CET头孢噻啶Cefaloridine 先锋Ⅱ号,头孢利素,CER,Kafspor头孢来星Cefaloglycine 先锋Ⅲ号,头孢甘酸,Kafocin,Kefglycin头孢氨苄Cefalexin 先锋Ⅳ号,苯甘孢霉素,头孢力新,CEX头孢唑啉钠Cefazolin Sodium 先锋Ⅴ号,塞福宁,西华乐林,先锋啉,凯复唑Cefalin,CEX,Cefamedin,Kefzol,Cramaxin头孢拉定Cefradine 先锋Ⅵ号,头孢雷定,头孢瑞丁,头孢环已烯,泛捷复,Velosef,CED,塞福定头孢乙腈Cefacetrile 先锋Ⅶ号,头孢腈甲,头孢赛曲头孢匹林Cefapirin 先锋Ⅷ号,头孢吡硫,Ceta-Dri头孢硫脒Cefathiamidine 先锋18,吡脒头孢头孢克洛Cefaclor 赐福乐素,新达乐,头孢氯氨苄,Ceclor,希刻劳,头孢克罗,可福乐,氯头孢菌素,CCL头孢羟氨苄Cefadroxil Cefadril,Kefroxil,羟氨苄头孢菌素,欧意,CDX,Duracef,Bidocef,Cefamx头孢沙定Cefroxadine 头孢环烯氨,ORASPON,CGP-9000,CXD头孢罗齐Cefprozil 头孢丙烯,Cefzil头孢替唑Ceftezole 特子社复,Tezacef,Alomen第二代头孢呋辛钠Cefuroxime Sodium 头孢呋肟,赐福乐信,舒贝洛,西力欣,特力欣,明可欣,CXM,Zinacef,Monacef,Ketocef,Furex Kesiut,Supero 头孢替安Cefotiam 噻乙胺唑头孢菌素,头孢噻乙胺唑,泛司博林,泛司颇灵,Pansparin,Halospor,CTM头孢呋辛酯Cefuroxime Axetil 头孢呋肟酯,新菌灵,西力达,头孢呋新乙酰乙酯Zinnat头孢西丁Cefoxitin 头孢氧唑,甲氧头霉噻吩,噻吩甲氧头孢菌素,美福仙,甲氧头霉噻吩,CXT,CFX头孢尼西二钠Cefonicid Disodium 铭乐希,Monocid,Cefonicid,Cefodie,Cefol头孢孟多Cefamandole 头孢羟唑,羟苄四唑头孢菌素,Mandolkef,CMT,Cefadole,Mandol头孢美唑钠Cefmetazole Sodium 先锋美他醇,氰唑甲氧头孢菌素,头孢氰四唑,头孢美他唑,CEFMETAZON,CMZ,Cemetol头孢布宗Cefbuperazone 头孢拉宗,Keiperazon,Tomiporan,Cefobutazine,CBPZ头孢雷特Ceforanide 头孢氨甲苯唑,头孢苄胺四唑,氨苄唑头孢菌素Precef第三代头孢地尼Cefdinir Cefzon头孢布坦Ceftibuten 头孢布烯,Cedax头孢卡品Cefcapene Pivoxil 头孢卡喷新戊酰氧甲酯,Flomox头孢噻肟钠Cefotaxime Sodium 头孢氨噻肟,泰可欣,塞福隆,菌必灭,治菌必妥,凯福隆,凯复龙,头孢噻肟,喜福得,Claforan,CTX头孢曲松钠Ceftriaxone Sodium 头孢三嗪,头孢泰克松,罗氏芬,罗噻嗪,菌必治,菌得治,头孢三嗪噻肟,泛生舒复,西华瑞隆,Rocephin,Ro-139904,CTRX 头孢哌酮钠Cefoperazone Sodium 头孢氧哌唑,先锋必,头孢必,达诺欣,塞福必,Cefobid,T-1551,CPZ头孢他啶Ceftazidime 头孢塔齐定,头孢羧甲噻肟,复达欣,凯复定,Glazidine,Fortaz,Eposerin,Modocin,Fotrum,Tazidime,CTZ,Spectrum,Eposerin,Modocin头孢唑肟Ceftizoxime 头孢去甲噻肟,益保世灵,安保速灵,Epocelin CZX,CEFTIZOX头孢克肟Cefixime 头孢烯噻羟肟,世伏素,世福素,FK027,Suprax,CFIX ,CEFSPAN头孢甲肟Cefmenoxime 头孢氨噻肟唑,倍司特克,BESTCALL,CMX头孢地嗪Cefodizime 头孢双唑,莫敌,莫敌威,Modivid,Timcef头孢匹胺Cefpiramide 先福吡兰,甲吡唑头孢菌素,头孢吡胺,CPM,Cefpiran,Sepatren头孢特仑酯Cefteram Pivoxil 头孢特仑新戊酰氧甲酯,托米仑,头孢他美酯,富山龙,Tomiron头孢磺吡苄钠Cefsulodin Sodium 头孢磺吡酮,头孢磺啶钠,磺吡苄头孢菌素钠,达克舒林,Cefsulodine,Takesulin,CFS,SCE129拉他头孢Latamoxef 羟羧氧酰胺菌素,拉氧头孢,头孢拉坦,噻吗灵Moxalactam,Shiomarin,Moxam,LMOX头孢米诺Cefminox 氨羧甲氧头孢菌素,美土灵,Meicelin头孢咪唑Cefpimizole Benilan,SPIE,Ajicef头孢替坦二钠Cefotetan Disodium 双硫唑甲氧头孢霉素,Yamatetan,CTT,Cefotan第四代头孢唑喃钠Cefuzonam Sodium Cosmosin,CZON氟氧头孢钠Flomoxef Sodium 氟莫克西,6315-S头孢匹罗Cefpirome 头孢吡隆,氨噻肟吡戊头孢其它Β-内酰胺类亚胺培南Imipenem 伊米配能,亚胺硫霉素,NFT氯曲南Aztreonam 菌克单,君刻单,噻肟单酰胺菌素,AZACTAM,Primbactam,Primbactin,SQ-26776氟罗培南Faropenem 福劳派南,Farom苄西林/氯唑西林Ampicillin/Cloxacillin 复方安比西林,爱罗苏,氨氯西林,白罗仙,淋必清,Pinocine亚胺培南/西司他丁Imipenem/Cilastatin 亚胺硫霉素/西拉司丁,泰能,TIENAM,PRIMAXIN阿莫西林/氟氯西林Amoxicillin/Flucloxacillin 氟羟西林,新灭菌,Biflocin,Infectrin三羟阿莫西林/单羟双氯西林Amoxycillin Trihydrate/Dicloxacillin康彼身,克菌,CompliscanΒ-内酰胺类抗生类+Β-内酰胺酶抑制剂氨苄西林/舒巴坦Ampicillin/Sulbactam 强力安必仙,舒他西林,优力新,新凯兰欣,舒氨欣,Unasyn,Sultamicillin头孢哌酮/舒巴坦Cefoperazone/Sulbactam 舒普深,舒哌酮,Sulperazone头孢噻肟/舒巴坦Cefotaxime/Sulbactam 新治菌哌拉西林/他佐巴坦Piperacillin/Tazobactam Tazocin,YP-14阿莫西林/克拉维酸Amoxillin/Clavulanic Acid 安灭菌,安美汀,奥格门汀,安美汀,阿莫克拉Augmentin,BRL25000替卡西林/克拉维酸Ticarcillin/Clavulanic Acid 泰门汀,特泯菌,特美汀,Timentin舒巴坦Sulbactam 舒巴克坦,陪他美,青霉烷砜氨基糖甙类链霉素Streptomycin RIMACTANE,RIFAMPINN,ovostrep庆大霉素Gentamycin 庆大霉素C,瑞贝克,正泰霉素庆大霉素链Gentamicin Chains 塞透派勒链,Septopal妥布霉素Tobramycin 立可信软膏,点必舒眼药水(妥布+地塞米松)泰星,妥布拉霉素,托普霉素,NEBCIN,Factorb,Brulamycin,Tobra,Nebramycin,Gernebcin,Obracine小诺霉素Micronomicin 小诺米星,沙加霉素,相模霉素,Sagamicin,Kw-1062,MCR核糖霉素Ribostamycin 威他霉素,维生霉素,Vistamycin,Ibistacin大观霉素Spectinomycin 奇霉素,壮观霉素,淋必治,奈毒素,Spectram,克淋,Trobicin,Kirin阿米卡星Amikacin 丁胺卡那霉素,Amikin,Likacin西索米星Sisomicin 西梭霉素,西索霉素,紫苏霉素,Sisomin,Sipeptin奈替米星Netilmicin 乙基西梭霉素,奈特,奈替霉素,乙基西素米星,立克菌星,乙基紫苏毒素,Ethylsisomicin,Vectacin,Zetamicn,Certomycin,NETROMYCIN 异帕米星Isepamicin 依克沙霉素,HAPA-B,Exacin阿司米星Astromicin 阿司霉素,福提霉素,武夷霉素,强壮霉素FORTIMICIN,Kw-1070,ASTM,Fortimicin地贝卡星Dibekacin 双去氧卡那霉素B,Dideoxykanamycin B,DKB,达苄霉素,Icacine依替米星Etimicin 悉能磷霉素类磷霉素Fosfomycin 福赐美仙,Phosphonomycin,Fosfocina,FOM磷霉素氨基丁三醇Fosfomycin Tromethamine Monurol。

化疗药物英文缩写之欧阳与创编

化疗药物英文缩写之欧阳与创编

Cisplatin,顺铂DDP Carboplatin卡铂,CBP 奥沙利铂Oxaliplatin,LOHP尼莫司汀Nimustine ,ACNU 卡莫司汀Carmustine ,BCNU环磷酰胺Cyclophosphamide,CTX 异环磷酰胺Ifosfamide,IFO 美司钠Mesna氮烯咪胺Dacarbazine,DTIC,DIC放线菌素 D Actinomycin D,ACD 博来霉素Bleomycin,BLM 丝裂霉素Mitomycin,MMC阿霉素Doxorubicin ,ADM 表柔比星Epirubicin,EPI 吡柔比星Pirarubicin,THP 米托蒽醌Mitoxantrone,MITX羟基脲Hydroxyurea,HU氟尿嘧啶Fluoracil, 5Fu 替加氟Tegafur,FT207卡培他滨(希罗达)Capecitabine,CAPE 吉西他滨(健择)Gemcitabine,GEM阿糖胞苷Cytosine arabinoside,AraC 氟达拉滨Fludarabine,FA甲氨蝶呤methotrexate,MTX 四氢叶酸Folinic acid,CF α干扰素Interferon alfa,IFNα白介素2 Interlukin2,rIL2重组粒细胞集落安慰因子Human granulocyte conlony stimulating factor GCSF长春碱Vinblastine,VLB 长春新碱vincristine,VCR长春地辛Vindesin,VDS 长春瑞滨(盖诺)Vinorelbine,NVB紫杉醇Paclitaxel,PTX/TAXOL 多西紫杉醇、泰索帝Docetaxel,DOC/DXL/TXT喜树碱Camptothecin ,CPT 羟喜树碱Hydroxycamptothecin,HCPT依立替康Irinotecan,CPT11 拓扑替康Topotecan,TPT足叶乙苷、依托泊苷Etoposide,VP16 替尼泊苷、威猛Teniposide VM26泼尼松Prednisone,PDN 他莫昔芬、三苯氧胺Tamoxifen,TAM 伊西美坦Exemestane,EXE来曲唑Letrozole,LTZ 甲地孕酮Megace,MA 阿那曲唑Anastrozole戈舍瑞林Goserelin depot 尼鲁特米Nilutamide门冬酰胺酶Asparaginase ,LAsp 全反式维甲酸Alltrans retinoic acid,RA填空:(根据英文名称写出药品名称与英文简写)Cisplatin, Carboplatin,Carmustine,Cyclophosphamide, Ifosfamide,Actinomycin D, Bleomycin,Mitomycin,Doxorubicin, Epirubicin,Hydroxyurea,Tegafur,Capecitabine, Gemcitabine, Cytosinearabinoside,methotrexate, Folinic acid,Interferon alfa,Human granulocyte conlony stimulating factor, vincristine,Vinorelbine,Paclitaxel,Hydroxycamptothecin,Irinotecan,Etoposide,Tamoxifen,Letrozole, Megace, Anastrozole Asparaginase, Alltrans retinoic acid,。

相关主题
  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

Abstract Advanced materials capable of responding to their chemical environment have been synthesized from the highly tailorable combination of sol–gel chemistry and epoxy-amine cross-linking reactions.Several materials were prepared from tetramethoxysi-lane (TMOS),and 3-glycidoxypropyltrimethoxysilane (GPTMS),and polyamine cross-linking agents.These cross-linking agents included diethylenetriamine (DETA),N -(2-aminoethyl)-piperazine (AEP Z ),1-(2-aminoethyl)-piperidine (AEP D ),and ethylenediamine (EDA).Selec-tive release of the indicator 4-methylaminoazobezene-4¢-sufonic acid from these materials was monitored using UV–visible spectroscopy.Studies of the release demonstrate that it is continuously pH responsive with the greatest release at extreme pHs.Release is triggered by changes in the electrostatic interactions between the molecular additive and the matrix.These interactions can be readily tuned by altering the cross-linking agent.IntroductionResponsive materials are of significant interest to materials chemists because of the range of potential applications including controlled drug-release [1],triggered-release of antimicrobial agents,biosensors [2,3]and active corrosion inhibition [4].There are anumber of routes to the formulation and preparation of these types of materials including the use of organic polymer,block copolymers,dendrimers,biomaterials and sol–gel derived materials.A recent paper by the Barrett group [5]describes the release of dye mole-cules from multilayer films prepared from two polyelectrolytes.In that work release was controlled via pH and was a function of the electrostatic inter-action between the dye molecule and the swelling of the material.In another example of controlled release [6]functionalized block copolymers have been used to control the release of hydrophobic drugs via hydrogen bonding.The interaction occurs between a functional group added to the block copolymer,and the func-tionalities present on the additive as a function of pH.These examples revolve around the use of organic polymers.Another approach to the formulation of controlled or triggered release is the use of sol–gel chemistry.These materials are typically inorganic or organic–inorganic hybrid in composition and are often more robust in extreme environments than purely organic polymer analogues.Additionally,their syn-thesis and encapsulation typically involves mild,aqueous conditions,which can represent a substantial advantage when incorporating chemically susceptible additives such as drugs.Research groups have demonstrated the encapsula-tion of small molecules in silane sol–gel prepared materials.Avnir demonstrated the encapsulation of dye molecules such as methyl red and Reichardt’s dye into gels prepared using the alkoxysilane tetramethoxysilane (TMOS)and alkylalkoxysilanes such as methyltri-methoxysilane (MTMOS)and vinyltrimethoxysilane (VTMOS)[7,8].Avnir found that by adding hydro-phobic alkylalkoxysilane to the sol–gel matrix,leachingM.E.Woods ÆA.J.Vreugdenhil (&)Department of Chemistry,Trent Institute for Materials Research,Trent University,1600West Bank Drive,Peterborough,ON,Canada,K9J 7B8e-mail:avreugdenhil@trentu.caJ Mater Sci (2006)41:7545–7554DOI 10.1007/s10853-006-0839-4Continuously responsive epoxy-amine cross-linked silicon sol–gel materialsMeghan E.Woods ÆAndrew J.VreugdenhilReceived:6October 2005/Accepted:10November 2005/Published online:24September 2006ÓSpringer Science+Business Media,LLC 2006of the dopant could be slowed or prevented due to a decrease in the ingress of water into the material.In that case,the inclusion of alkylsilanes such as MTMOS and VTMOS were used to modify the hydrophobicity of the material without utilizing the organic functionality of the silane for subsequent reactions.Using the same principles,the release of molecular additives from silane sol–gel materials can also be con-trolled.In previous work,we have demonstrated that the appropriate amount of MTMOS added to a cross-linkable matrix could lead to improved wet adhesion while maintaining the triggered-release character of the material[9].Bottcher[10]has demonstrated the con-trolled release of biocides from sol–gel prepared xero-gels of tetraethoxysilane(TEOS).Release in this case is controlled by the ratio of silica to biocide and by the addition of hydroxypropylcellulose.In that case and in similar research,sol–gel materials have been prepared from alkoxysilane precursors creating an inorganic matrix where release is mediated through control of pore size,the dissolution of a sacrificial organic polymer or the modification of surface polarity via the addition of an alkylalkoxysilane[11].This approach is effective for many applications however;it is limited by the fact that after initiation the materials are not sensitive to their immediate chemical environment.This work describes the triggered-release behavior of a series of cross-linked sol–gel materials in which release is continuously responsive to the chemical surroundings.Sol–gel materials were prepared through the acid-catalyzed hydrolysis and subsequent condensation of3-glycidoxytrimethoxy silane(GPTMS)and TMOS.Be-cause of the large H2O:Si ratio used in this formula-tion,gelation does not occur.This allows for the utilization of epoxy-amine cross-linking for solidifica-tion of the material and incorporation of the amine moieties into the solid.There are a number of known methods for cross-linking epoxy functionalities including the use of strong acids such as HCl,thermally curing the material and photo polymerization.We have chosen to use room temperature epoxy-amine chemical cross-linking.This method is desirable because it is fast and efficient,adds an additional functionality to the coating and allows for the use of different types of polyamines in the cross-linking step.Here,we describe the critical role that amines play in the triggered-release of molecular addi-tives.These cross-linked materials demonstrate pH-dependent triggered-release,which is a function of electrostatic interactions between the molecular additive and the matrix.These interactions are domi-nated by the amine moieties resulting form the epoxy amine cross-linking process.The crucial role of the amine cross-linker has been confirmed by studying the changes in the triggered-release profiles when different polyamines are used and by comparing these systems with the release profile of uncross-linked TMOS and GPTMS:TMOS materials.pH exposure cycling experi-ments demonstrate the ongoing responsive nature of these materials to their chemical environment.Three organic cross-linkers,ethylenediamine (EDA),N-(2-aminoethyl)piperazine(AEP Z)and1-(2-aminoethyl)-piperidine(AEP d),were considered in this study(Fig.1).Triggered-release of an additive from DETA cross-linked materials has previously been studied and was used as a benchmark in this study[9].The additional cross-linkers were selected for their structural differences or similarities to DETA.EDA is essentially a truncated version of DETA.AEP Z was chosen as a cross-linker because of its cyclic structure in contrast to the linear structures of EDA and DETA. AEP z was expected to lead to a more rigidly cross-linked material because of its cyclic structure.A fourth amine-containing molecule was added to this study, AEP d,to aid in elucidating the behaviour observed for AEP z materials.AEP d and AEP z differ from each other by one secondary amine in AEP z.Additionally both AEP z and AEP d are of interest for applications of these materials as active corrosion suppression coatings.The molecular additive chosen for this work was the pH indicator methyl orange.This additive was selected for its easily quantifiable release using UV–visible spectroscopy and the fact that it contains several func-tional groups often present in molecules of practical interest for triggered-or controlled-release.While the triggered-release profile characterized in this work is specific to methyl orange,we believe that an under-standing of what drives release,in particular the elec-trostatic interactions occurring between the matrix and functional groups of the additive,will allow for the prediction of the triggered-release profiles of different additives from this type of material.The cross-linked materials were characterized through solid-state NMR measurements,Raman and IR spectroscopy,p K a computation,triggered-release experiments,pH cycling experiments,and zeta poten-tial measurements.Experimental1:3Tetramethoxysilane:3-glycidoxypropyltrimethoxysilaneThe1:3TMOS:GPTMS(Sigma-Aldrich)coating was prepared by drop-wise addition of a mixture of0.02molof TMOS and0.06mol of GPTMS to21.60·10–6m3of acidified deionized H2O(0.05M acetic acid).Once the addition was completed,the solution was allowed to age closed for72h with continuous stirring.Following aging,19.38·10–6m3of a surfactant solution(0.1%w/ w solution in deionized H2O of3M Flourad)was added. The solution was gently stirred andfiltered using a 0.8l m cellulose acetatefilter(Cole-Parmer).The cross-linker DETA,EDA,AEP z or AEP d(Sigma-Aldrich)was added to the sol in a1:1ratio of epoxide to amine proton with an equivalent volume of H2O.Into the resulting solution clean,glass substrates were dip-ped.Each slide received three consecutive dips into the solution before being allowed to air dry at room tem-perature for24h.The edges of the slides were taped to create a well-defined surface area with minimal per-turbation from edge effects for leaching purposes.The pH indicator methyl orange(4-methylaminoazoben-zene-4¢-sulfonic acid)was incorporated into the coat-ings following the addition of the silane to the acidified H2O.It was determined in previous research that a 0.5%w/w mass of molecular additive is an appropriate amount in order to observe significant leaching from the coatings without disturbing the mechanical or chemical properties of the matrix[9].TMOS coatingTo identify the factors affecting the triggered-release process,a tetramethoxysilane onlyfilm was also prepared.About0.05mol of TMOS(Sigma Aldrich) was added drop-wise to21.6·10–6m3acidified H2O. The solution was allowed to for age2h with continu-ous stirring.Following aging,the solution was removed from the stir plate;19.38·10–6m3of a surfactant solution(0.1%w/w solution in deionized H2O of3M Flourad)was added.The solution was stirred manually and thenfiltered using a0.8l m cellulose acetatefilter (Cole-Parmer).Coatings were prepared as described above.Zeta potential measurementsThe1:3coating was prepared as described above however,instead of the addition of a cross-linking agent,an amine epoxide terminating species was used.Two different terminating groups were chosen: diethylamine(DEA,Sigma Aldrich), 6.65·10–6m3 (0.06mol)or N,N,N¢-trimethylethylenediamine(MEDA, Sigma Aldrich),2.03·10–6m3(0.06mol)was added to the solution following thefiltration step.About0.05g of Snowtex-ZL silica particles(Nissan Chemical Industries)were added to3·10–6m3of the termi-nated sol–gel,the mixture was sonicated for2min and then placed in a centrifuge for3min.The sol–gel solution was then decanted off the coated silica parti-cles.The above procedure was performed three times, after thefinal repetition;the particles were suspended in5·10–6m3of distilled water.This protocol results in nanoparticle substrates coated with amine terminatedsol–gel material suitable for zeta potential analysis.A very similar process has been described elsewhere and has been used in zeta potential analysis of polymeric coatings and sol–gel derived materials[9,12].The zeta potential measurements were performed using a Brookhaven ZetaPlus:Zeta Potential Analyzer. The sol–gel coated colloidal silica was studied using microelectrophoresis over a pH range of2.0–12.5.The studies were carried out in a solution of deionized water.Twenty zeta potential measurements were taken for each of the pHs at afixed temperature of25°C.Substrate preparationThe substrates used were plain glass microscope slides (Corning2947),cleaned as follows:3min sonication in methanol,followed by a3min immersion in concen-trated KOH/ethanol,followed by3min of sonication in distilled water.The slides were rinsed between steps with distilled water to avoid contamination of the dif-ferent baths.After completely drying in air,a surface treatment was applied to the slides.The surface treatment was a solution of GPTMS(4.42·10–6m3) combined with acidified H2O(36.0·10–6m3)in a drop-wise manner.The solution was stirred for30min. Clean substrates were immersed in the resulting solu-tion for20min and allowed to dry for12h. Triggered-release protocolThe triggered-release studies were performed in seven different buffered solutions with one slide per solution. The buffered solutions spanned the pH range from2.5 to11.0.The buffers for the range between2.5and5.0 were prepared from a0.1M solution of sodium ace-tate,the6.0–8.0range was prepared from a solution of NaH2PO4with a concentration of0.1M,and the range form9.0–11.0was prepared from a solution of con-centration0.1M of Na2HPO4.The pH of all of the buffered solutions was adjusted using either concen-trated HCl or NaOH.The coatings were leached over a period of1440min into50·10–6m3of buffered solution.Thefirst sample was removed after20min of exposure to the buffered solution(approximately 3·10–6m3)two additional samples were taken after 60and90min had passed.A fourth sample was taken at the120-min point and every60min after that for a total of360min.Afinal sample was taken after a total of1440min.Once all the samples were collected,the pH of each sample was adjusted to2.5using concen-trated HCl.This pH corresponds to the highest molar absorptivity for methyl orange.The UV–visible spectra of the leachate were measured using an Ocean Optics B2000USB-ISS-UV/VIS spectrometer between400and600nm.Raman spectroscopyRaman spectra were obtained on a Reinshaw inVia Raman microprobe with an excitation wavelength of 633nm,from a helium neon laser at a maximum power of20mW.Samples were dip-coated onto aluminum substrate and the spectrum was acquired with a typical exposure time of3min.Infrared spectroscopyGrazing angle IR spectra of the coatings on aluminum alloy substrates were obtained on a Bruker Equinox55 Spectrometer with liquid nitrogen cooled MCT detec-tor.Typically,100co-added sample scans were ratioed against scans from a gold mirror background to generate the log reflection spectra presented here.NMR spectroscopyAll solid-state29Si and13C NMR spectra were obtained at a frequency of515Hz on a Bruker ASX-200NMR spectrometer using a5mm solid-state probe.Spectra were obtained at294K.Spectra were acquired for3h to achieve the desired signal to noise.ResultsAdhesion testIt is important that these materials demonstrate good wet adhesion for a number of reasons;in particular, good wet adhesion insures long lifetimes for the coat-ing as many of the proposed applications involve the exposure of these materials to wet environments.It also insures that the primary release mechanism is something other than simple coating delamination.As well,all release studies are performed while coatings are submerged into aqueous solutions for several hours to several days.Good wet adhesion under such cir-cumstances is necessary for these measurements to be made.Good adhesion was judged to be the absence of visible blistering orflaking of the coating during the adhesion tests.The coatings’wet adhesion performance varied as a function of the amine cross-linker.EDA cross-linked materials demonstrated the best performance with excellent adhesion in dilute Harrison solution(3.5% ammonium sulphate and0.5%NaCl)for over12months.By contrast,AEP z had the poorest adhe-sion with delamination occurring after only2h in solutions of all pHs and ionic strengths.Triggered-releaseThe triggered-release profiles of the coatings were studied over a period of24h.All coatings containing the molecular additive were orange in colour initially and remained unchanged throughout the triggered-release period indicating that not all of the molecular additive was removed from the matrix over the release study.The triggered-release profiles for all of the coatings are shown in Fig.2.They are subtly different from one another with EDA and AEP d having release minima at pH 6.0;DETA and AEPz at pH 5.0. Triggered-release experiments performed with TMOS and uncross-linked TMOS:GPTMS coatings had very different results from those of the cross-linked mate-rials.A comparison of triggered-release from TMOS and from a DETA cross-linked material is shown in Fig.3.pH cyclingpH cycling experiments were carried out for all of the coatings.The samples were alternated between extreme pH(2.5or11.0)and moderate pH(6.0). Typical results are presented in Fig.4.The materials demonstrated an instantaneous response to their pH environment[9].Zeta potential measurementsZeta potential measurements allow for the isoelectric point of the coating to be estimated by studying the behaviour of coated nanometer diameter silica parti-cles under the influence of an electricfield in solution as a function of pH.The charge on the coated particle is determined to be zero at the pH where it demon-strates no mobility in an electricfield.Given that the charge behaviour of a non-conducting coating and particle will be dominated by the composition of the coating,this procedure effectively measures the zeta potential of the sol–gel coatings described here.Thisapproach has been established previously for layers of organic polymers on nanoparticle silica[12].The result of this measurement is shown in Fig.7. The isoelectric point for the EDA cross-linked coating is approximately10.20,and is entirely dif-ferent from that observed for uncoated silica particles [12].p K a determination for cross-linked materialsUsing ACD/pka software accessed through ACD/I-labs,we computed the p K a’s for various moieties representing the likely products of the epoxy-amine cross-linking reaction(Table1).From this work,it is clear that as the amines become more substituted their pKa’s drop,making them better nucleophiles.Fully substituted cross-linkers were found to be fully de-protonated at pH8.59for AEP d,7.78for AEP z,7.69 for EDA and7.41for DETA.Epoxide consumption measurementsTo identify the species present in the matrix following film preparation,epoxide consumption was studied for both monoliths and coatings using13C solid-state NMR,Raman and infrared spectroscopy.The absence of peaks in the solid-state13C-NMR spectra at50and 44ppm and1250cm–1in the Raman indicate that all of the epoxide groups have been consumed in the monoliths[14].Raman spectroscopy of the coatings demonstrates that the epoxide groups remain for slightly longer period than those in the monoliths.The coatings exhibited peaks at1250cm–1for up to96h after the coatings were visually dry.IR spectroscopy confirms this result and suggests that mostly tertiary amines remain indicating completion of the epoxide amine cross-linking.Previous results by Vreugdenhil et al.on a similar coating support this result[15].Table1Amine-containing components and their respective pKa’sThese results were obtained using ACD/pka v.8.02via the ACD/I-lab service)[13]Component Derived from p K a1p K a2p K a3R2NCH2CH2NRCH2CH2NHR2DETA 2.16±0.507.04±0.197.41±0.19 R2NHCH2CH2NHR2EDA 5.38±0.217.69±0.50 NNN RRRAEP z 2.22±0.50 6.11±0.197.78±0.25 NN RR AEP d 5.96±0.198.59±0.20R2NCH2CH2NHCH2CH2NHR DETA 2.22±0.507.05±0.508.86±0.19 R2NCH2CH2NHR EDA 5.78±0.508.81±0.19NNHNH R2AEP Z 2.33±0.507.57±0.509.45±0.25DiscussionCharacterization of amine moieties in the material Solid-state13C NMR and Raman spectroscopy of monoliths of these materials indicate that all epoxides are consumed in thefinal material(Fig.5).Raman spectroscopy of the coatings suggests that the epoxides are present initially after coatings are prepared.How-ever,within96h,all epoxides are consumed.The dif-ference between these two results can be accounted for by the significantly longer drying time required for monoliths versus coatings(1h vs.3min)allowing for longer interaction time between the epoxide groups and the cross-linking amines.The epoxide consump-tion for the coatings as a function of amine cross-linker is shown in Fig.6.These results show that over a period of48h most of the epoxide groups are con-sumed:80%for DETA cross-linked materials,70%for EDA and100%for AEP z.After96h,all epoxides in all coating formulations are consumed.Raman investigations of the epoxide consumption, AEP z was the most efficient cross-linker requiring only 24h to reach complete epoxide consumption.The epoxide–amine cross-linking mechanism is a nucleo-philic attack of the epoxide group by the lone pair of electrons on the amine,as more amines become func-tionalized during the cross-linking reaction they be-come better nucleophiles.However,as the amines react with the epoxides in the sol–gel coating,steric hindrance of the bulky groups attached to the epoxides are expected to slow down the rate of the reaction. Additionally,increasing rigidity of the cross-linked solid reduces the mobility of the epoxide and amine groups.Wet adhesion and cross-linker hydrophobicityAs previously mentioned,the wet adhesion of the coatings is of particular importance for elucidating the triggered-release mechanism.IR and Raman results indicate that all epoxide groups are consumed sug-gesting that the coatings are densely cross-linked and should ideally act as efficient water barriers[16,17]. However,wet adhesion experiments for the AEP z cross-linked coatings demonstrated poor wet adhesion over the entire pH range,with the coating bubbling due to water penetration and eventually delaminating entirely from the substrate.This behaviour was not observed for the three other coating systems studied.The success of the DETA and EDA cross-linked is not unexpected.However,the durability of the AEPd Fig.513C Solid state NMRfor EDA cross-linkedmonolithcross-linker system was somewhat unanticipated given the similarities between AEP z and AEP d.One expla-nation is that the performance differences between AEP z and AEP d cross-linked coatings could be due to an increase in the hydrophilicity of the materials given that AEP z is a more hydrophilic molecule with an additional secondary amine in its6-member ring (Fig.1).This hydrophobic/hydrophilic difference is also suggested by the triggered-release results for AEP d(Fig.3)where release from this coating was approximately1/3less than that observed for AEP z formulated coatings.As demonstrated by Avnir’s work on MTMOS and VTMOS materials[18],we ascribe this difference to the fact that the hydrophobic nature of the cross-linker will result in a slower ingress of water into the material.AEP z on the other hand releases the most additive due to an increase in hydrophilicity allowing for more facile ingress of water into the coating.Cross-linker dependent triggered-releaseThe triggered-release profiles for EDA,DETA,AEP d and AEP z coatings are shown in Fig.2.Overall,the release profiles share the same general horseshoe shape;however,the results of the triggered-release experiments demonstrate that the use of different cross-linkers can be used to subtly tune the triggered-release profile of the material.This is most readily apparent in the dependence of release minima for the different formulations.This occurs at pH 5.0for materials cross-linked with DETA and AEP z and pH 6.0for EDA and AEP d cross-linked materials.As well, the EDA and AEP z-triggered release profiles have an asymmetric appearance with more additive being released at basic pH than at acidic.DETA and AEP d have profiles that are more symmetrical.A comparison between DETA’s release profile and TMOS only release coating emphasizes the responsiveness of the cross-linked coatings(Fig.3).Uncross-linked TMOS-GPTMS also shows no responsiveness to their chemi-cal environment in the release profile.We have used a number of tools to characterize the coatings and clarify the triggered-release dependence on the amine cross-linker.The only difference between the materials investigated in this work was the cross-linker used in the formulation.Although the rate of epoxide consumption varied slightly as a function of the amine used,all coatings achieved complete epoxide consumption within96h.IR spectroscopic studies suggest the presences of mostly tertiary amines in all cross-linked coatings rather than secondary or primary amines.In light of the fact that the amines in the coating dominate the electrostatics of the system and the triggered release mechanism is primarily an elec-trostatic one,an investigation of the charge states associated with the coating was conducted.The electrostatics of the coating were studied using two approaches.First,zeta potential was used to study the behaviour of silica particles coated with a model of the EDA cross-linked coating.These results are presented in Fig.7.The isoelectric point for the modeled material occurs at pH10.20.The four coatings studied differ only in the amine used to cross-link them.The ratio of silane precursors and the formulation conditions are the same in every case.The isoelectric point of the silica particles is known to be 2.3[12]and primarily silica-coated materials have similar acidic behaviour.The basic isoelectric point observed for these sol–gel-derived materials clearly indicates that the charge state of the coating is dominated by the amines used in the cross-linking process.In an effort to identify the electrostatic behaviour of the different moieties that may be present in the coating as a result of the epoxy amine reaction,the p K a was calculated for the cross-linkers themselves and several likely epoxy-amine reaction products as suggest by IR and Raman results[13].These species are shown in Table1.The calculated p K a’s suggest that each of the coatings are fully deprotonated and therefore neutral above pH8.5.This is lower than the pH pre-dicted using zeta potential,which was a pH of10.2. Given the assumptions in each of these models,it is likely that the true isoelectric point for the coating falls somewhere between the zeta potential result and the p K a calculations.Both models are useful in bracketingthe electrostatic behaviour of the cross-linked sol–gel materials and demonstrating the important role of the amines in the triggered-release process.If we consider all of the electrostatic data for the coatings and the molecular additive methyl orange,the electrostatic interaction becomes clear(Fig.7).Methyl orange is zwitterionic between pH2.5–3.0and become negatively charged around pH4.0;it carries this neg-ative charge over the rest of the triggered release pH range.From both the pKa result and the zeta potential measurements,we know that the coating is positively charged between pH 2.5and 3.0.We expect little interaction between the coating and the additive in this range and uninhibited release of the additive from the coating.EDA and AEP d coatings are expected to be fully positively charged until approximately pH5.38 for EDA and5.96for AEP d.These pHs correspond well with the triggered release minima observed for the coating cross-linked with EDA or AEP d.DETA and AEP z on the other hand loose theirfirst proton at pH ~2.0an additional proton is lost by these amines at approximately pH7.04.As the pH increases,the epoxy-amine cross-links undergo further deprotona-tion resulting in the coating carrying no charge.In this region,an increase in the amount of methyl orange released from the coating is observed as the electro-static interaction between coating and additive decreases.Due to the fact that electrostatic interactions dominate the triggered release behaviour,these cross-linked sol–gel materials should continuously respond to their immediate chemical.In order to evaluate this aspect of their release behaviour pH cycling experiments were carried out on each of the coatings.In these experiments,coatings were cycled between moderate and extreme pHs.Extreme pH exposure produced the expected maximum release. Cycling the samples to moderate pH resulted in minimal release(Fig.4).Release profiles from these experiments demonstrate that the materials respond continuously to their local pH,independent of the pH to which they had previously been exposed.This novel behaviour indicates that little to no coating degradation occurs during the release experiments and further emphasizes the continuing responsiveness of the materials to their current chemical environ-ment.ConclusionThis work demonstrates the role that amine cross-linkers play in the triggered release of molecular additives from alkylalkoxysilane sol–gel coatings.The results of this work expand the proposed electrostatic mechanism previously described by us for a single amine cross-linker[9].A thorough study of the iso-electric point of the coatings has been performed using zeta potential measurements and computation of p K a’s for a variety of species potentially present in the material.These studies,in combination with the release profiles for the coatings cross-linked with DETA,EDA,AEP z and AEP d,allow for a satisfac-tory elucidation of the release mechanism.Cross-linking efficiency of the four amines has also been characterized providing a better understanding of the coatings matrix.The pH cycling experiments have highlighted the continuous responsiveness of these coatings to their immediate chemical environment. This work permits us to readily identify new additives and to estimate their triggered release behaviour.This knowledge will be applied to the triggered release studies of additives selected for their target applica-tions.It is hoped that with a full understanding of triggered release,it will be possible to precisely tune these materials to release additives only under very specific environmental conditions and that these materials will remain continuously responsive pri-marily by selecting the appropriate cross-linking agent.Acknowledgement The authors thank Franc¸oise Sauriol of Queen’s University Chemistry department for the solid state NMR results.Financial support for this work was provided by Trent University and the Natural Sciences and Engineering Research Council of Canada.References1.Kang SI,Na K,Bae YH(2003)Colloids Surf A PhysicochemEng Asp231:1032.Mahltig B,Fiedler D,Bottcher H(2004)J Sol–Gel Sci Tech32:2193.Ertekin K,Cinar S,Aydemir T,Alp S(2005)Dyes Pigments67:1334.Acros D,Pena J,Vallet-Regi M(2003)Chem Mater15:41325.Burke SE,Barrett CJ(2004)J Macromol37:53756.Lee J,Cho EC,Cho K(2004)J Control Rel94:3237.Rottoman C,Turniansky A,Avnir D(1998)J Sol–Gel SciTech13:178.Rottoman C,Grader G,Avnir D(2001)Chem Mater13:36319.Vreugdenhil AJ,Woods ME(2004)Prog Org Coatings53:11910.Bottcher H,Jagota C,Trept J,Kallies K-H,Haufe H(1999)JControl Rel60:5711.Bottcher H(2000)J Prakt Chem342:42712.Burke SE,Barrett CJ(2003)Langmuir19:329713.ACD/Chemsketch,Ó1994–2005,Advance ChemistryDevelopment Inc.ACD/Labs Release version8.17,build:28。

相关文档
最新文档